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Abstract 
Individuals with adult attention-deficit/hyperactivity disorder (ADHD) present with 
deficits in attention, hyperactivity-impulsivity, or a combination of these symptoms.  
Functional impairment due to inattention, reduced motivation, poor impulse control, 
emotion dysregulation, and deficits in executive functioning are also frequently seen.  
Assessment of ADHD, using objective continuous performance tasks, has been 
introduced in conjunction with widely used self-report measures of ADHD symptom 
severity.  The Conner’s Adult ADHD Rating Scale (CAARS) is one such self-report 
measure of ADHD, consisting of 66 self-report items that measure symptoms of ADHD, 
including inattention, hyperactivity, impulsivity, and poor self-concept.  The Quotient 
ADHD System purports to provide objective measures of ability to inhibit motor activity, 
maintain attention, and suppress impulsive responses.  The Quotient ADHD System has 
been found to be sensitive to the pharmacologic effects of ADHD medication.  Currently, 
there is a lack of empirical evidence for the Quotient ADHD System in an adult 
population, specifically, indicating a relationship between evaluations using the Quotient 
ADHD System and a widely accepted self-report measurement of ADHD, such as the 
CAARS.  The present study determined that the global scaled score and motion scaled 
score metrics of the Quotient ADHD System correlate with the Hyperactive/Restlessness 
scale on the CAARS.  Furthermore, the present study found a significant positive 
correlation between the Inattentive Metric of the Quotient ADHD System and the 
Inattention/Memory scale on the CAARS.   
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Introduction 
Attention-deficit/hyperactivity disorder (ADHD) is a pervasive 
neurodevelopmental disorder that persists from childhood through adulthood for up to 
60% of individuals (5th ed., DSM–5; American Psychiatric Association [APA], 2013; 
Agnew-Blais, Seidman, & Buka, 2013; Kessler et al., 2006; Rowland et al., 2015).  
According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, 
(APA, 2013), ADHD is a persistent pattern of inattentiveness, hyperactivity-impulsivity, 
or a combination of the two.  
According to the DSM−5 criteria, a diagnosis of ADHD includes six or more 
symptoms in children, or five or more symptoms in adults, that persist for over 6 months 
and negatively impact academic, occupational, or social activities (APA, 2013).  
Symptoms of inattention have been characterized as failure to give attention to detail, 
difficulty sustaining attention in tasks, appearing absent-minded even when spoken to 
directly, failure to follow through on instructions or schoolwork or occupation-related 
tasks, difficulty organizing tasks, avoidance of attentionally demanding tasks, losing 
things, distractibility, and forgetfulness (APA, 2013).  Symptoms of hyperactivity and 
impulsiveness have been characterized as fidgeting, difficulty remaining seated, feelings 
of restlessness in adults or overactivity in children, difficulty engaging in leisure 
activities quietly, discomfort with sitting still for extended periods of time, excessive 
talking, interruption in conversation, difficulty waiting their turn, and frequent intrusion 
on others’ activities (APA, 2013).  
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The predominately inattentive subtype of ADHD is characterized by the presence 
of six or more symptoms related to inattention in children or five or more of the 
symptoms in adolescents or adults.  The predominately hyperactive/impulsive subtype of 
ADHD is characterized by the presence of six or more of the symptoms related to 
hyperactivity/impulsivity in children or five or more of the symptoms in adolescents or 
adults.  Finally, ADHD – combined type is characterized by the presence of six or more 
symptoms in children or five or more symptoms in adolescents or adults related to 
inattention and hyperactivity/impulsivity (APA, 2013).        
 In adulthood, difficulties related to relationship quality, health, legal issues, 
unemployment, financial concerns, and academic failure have been found to be more 
prevalent among individuals with ADHD (Kessler et al., 2006; Ramsay, 2010a).  
Furthermore, ADHD was estimated to result in an excess annual cost of $31.6 billion in 
the United States in 2000, specifically $1.6 billion for treatment, $12.1 billion for 
additional health care costs, $14.2 billion for additional healthcare costs to families, and 
$3.7 billion for work loss costs (Robb et al., 2011).     
Assessment of ADHD is often conducted using self-report and other-report 
surveys, with the latter based upon information collected from collaterals.  Self-report 
measures have demonstrated diagnostic validity and allow the patient to report symptoms 
as they perceive them (Erhardt, Epstein, Conners, Parker, & Sitarenios, 1999; Kooij et al., 
2008).  Given the aforementioned considerations, however, individuals with ADHD 
experience deficits in performance monitoring and self-awareness and therefore often 
underreport deficits and other symptoms (Erhardt et al., 1999; Kessel & Zimmerman, 
1993; Knouse, Bagwell, Barkley, & Murphy, 2005; Prevatt et al., 2011).  Other-report 
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surveys are often included in the assessment of ADHD to provide supplementary 
information to overcome some of these problems (Erhardt et al., 1999; Kessel & 
Zimmerman, 1993; Kooij et al., 2008).  Ratings of inattention and hyperactivity are often 
higher based on an informant report than on a self-report prior to medication treatment, 
whereas following medication treatment, self-report and other report scores show a 
tendency to converge (Adler et al., 2007; Nelson, 2011; Prevatt et al., 2011).   
Incorporation of both self-report and other-report is most often recommended in 
assessment of ADHD because each method provides unique information that can 
collaboratively inform diagnosis (Goldstein & Ellison, 2002; Kennedy, 2007).  
Furthermore, the use of multiple forms of assessment allows the clinician to develop a 
more comprehensive understanding of presenting symptoms and implications for 
academic, occupational, and social functioning.   
Often, assessment of ADHD incorporates direct behavioral measures.  Continuous 
performance tasks are frequently used because they measure sustained attention.  Motion-
based continuous performance tasks measure locomotor activity, in addition to 
accounting for sustained attention (Conners & Staff, 2000; Sumner, 2010; Teicher, 
Lowen, Polcari, Foley, & McGreenery, 2004).   
Computer-based continuous performance tasks that account for motion have 
recently been incorporated into the assessment of ADHD, as they provide a means of 
assessment less susceptible to response bias, demand characteristics, and social 
desirability (Goldstein & Ellison, 2002; Hall et al., 2015; Kooij et al., 2008; Sumner, 
2010).  Such measures are suggested to supplement survey report measures in the interest 
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of providing a more comprehensive diagnostic conceptualization (Hall et al., 2015; 
Sumner, 2010; Teicher, Polcari, & McGreenery, 2008). 
A search of the Google Scholar, PsychInfo, and EBSCO databases failed to find 
published research on the relationship between ADHD symptom severity as measured by 
a widely used and psychometrically sound, self-report assessment measure, specifically, 
the Conners’ Adult ADHD Rating Scale (Conners et al., 2002), and ADHD severity as 
measured by an objective, motion-based assessment test, specifically, the Quotient 
ADHD System (Sumner, 2010).  In contrast, most previous research has measured 
ADHD severity using only self- and other-report measures (e.g., Goldstein & Ellison, 
2002; Kooij et al., 2008; Mörstedt, Corbisiero, Bitto, & Stieglitz, 2015; Sumner, 2010).   
The Quotient ADHD System is an example of an objective computer-based 
continuous performance task (CPT).  CPTs provide data that is less susceptible to 
response bias, demand characteristics, and social desirability (Kooij et al., 2008; 
Mörstedt, Corbisiero, Bitto, & Stieglitz, 2015; Teicher, Ito, Glod, & Barber, 1996; 
Teicher et al., 2004).  In addition, the Quotient ADHD System incorporates motion 
measurements into assessment of ADHD, unlike many other continuous performance 
task measurements (Conners & Staff, 2000; Stein, Snyder, Rugino, & Hornig, 2016; 
Sumner, 2010; Teicher et al., 2004, 2008).  
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Literature Review 
History of ADHD 
ADHD is a neurodevelopmental disorder characterized by problems with 
executive functions, including attentional control and inhibitory control, that result in 
attention deficits, hyperactivity, and/or impulsivity (Daley, 2006; Solanto, 2015).  It is 
likely that ADHD has been present among humans throughout recorded history; however, 
George Still is credited with the first formal clinical identification of ADHD, referring to 
it as a difficulty with “moral control without general impairment of intellect and without 
physical disease” (Still & Cantab, 1902, p. 1077).  In the 1930s, while working with 
children with behavioral disorders, pediatrician Charles Bradley discovered the benefits 
of stimulant medications for reducing impulsivity and promoting behavioral self-control 
(Bradley, 1937).  Bradley noted that children taking Benzedrine appeared “emotionally 
subdued without, however, losing interest in their surroundings” (Bradley, 1937, p. 580).  
The use of Benzedrine in children with behavioral disorders produced substantial 
improvements in academic performance.  Bradley noticed that when taking Benzedrine, 
children with behavioral disorders were also able to demonstrate more appropriate social 
behavior, although he stressed that medication was a temporary solution and did not 
correct the underlying problem (Bradley, 1937; Strohl, 2011). 
The history of American interest in ADHD can be traced to the encephalitis 
epidemic, which occurred between 1917 and 1918.  A number of children who survived 
the brain infection were left with significant cognitive and behavioral difficulties 
(Conners & Staff, 2000; Sumner, 2010; Teicher et al., 1996). During the 1950s, 
researchers began to investigate potential neurological mechanisms that may underlie the 
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behavioral symptoms of what was then called hyperkinetic impulse disorder and reasoned 
that deficits resulted from abnormalities in the central nervous system (CNS) (Laufer, 
Denhoff, & Solomons, 1957, pp. 1).  At the time, it was suggested that the existence of an 
imbalance between subcortical and cortical areas of the brain resulted in diminished 
control of the subcortical areas responsible for filtering sensation and thus permitted 
stimulation from sensation to reach the cortex, resulting in overstimulation (Knobel, 
Wolman, & Mason, 1959).  This was thought to result in increased perception of 
extraneous stimuli and hence difficulties in attention (Knobel, Wolman, & Mason, 1959; 
Laufer et al., 1957). 
 The first appearance of a behavioral health disorder resembling what is now 
known as ADHD occurred in the second edition of the Diagnostic and Statistical Manual 
of Mental Disorders (2nd ed.; DSM−II; American Psychiatric Association, 1975), 
referring to it as a hyperkinetic reaction that occurred during childhood.  The DSM–III 
introduced the term attention deficit disorder (ADD) (American Psychiatric Association, 
1980, p. 41-44).  The term was then revised to ADHD in the DSM−III−R (American 
Psychiatric Association, 1987, p. 50). The DSM−IV was the first to take into account 
attention deficits and their occurrence with or without hyperactivity (American 
Psychiatric Association, 1994).  Currently, the DSM−V specifies several criteria that must 
be met to warrant a diagnosis of ADHD (American Psychiatric Association, 2013). 
Whereas children and young adolescents must have at least six symptoms of inattention 
and/or hyperactivity-impulsivity, older adolescents and adults (ages 17 and older) must 
have at least five symptoms of inattention and/or hyperactivity-impulsivity.  Moreover, a 
diagnosis of ADHD is based on symptoms of predominant inattentiveness, predominant 
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hyperactivity-impulsivity, or combined inattention and hyperactivity-impulsivity 
(American Psychiatric Association, 2013).         
During the mid to late 1990s, neuropsychological research began to examine 
variations in brain functioning, especially with regard to the frontal lobe, among those 
meeting ADHD symptom criteria.  One study examined verbal fluency in the evaluation 
of ADHD (Koziol & Stout, 1992).  Further investigation was conducted into neurological 
mechanisms underlying ADHD, including comparison to reading disabilities in children 
(Hall, Halperin, Schwartz, & Newcorn, 1997).  Adult ADHD was investigated in terms of 
adaptive functioning and comorbidities (Murphy & Barkley, 1996).  Another study found 
deficits in adults with ADHD in semantic verbal encoding, vigilance, and written 
arithmetic tasks (Seidman, Biederman, Weber, Hatch, & Faraone, 1998).  
Contemporary understanding of adult ADHD.  
ADHD is currently theorized to be a neurodevelopmental psychiatric disorder 
with manifestations in biological, psychological, and social domains.  According to 
Barkley, the origin of such manifestations stems from deficits in behavioral inhibition 
and four related executive abilities: working memory, internalization of speech, self-
regulation, and reconstitution (1997).  Working memory has been defined as “the ability 
to keep an item of information in mind in the absence of an external cue and utilize that 
information to direct an impending response” (Goldman-Rakic, 1995, p. 57). 
Internalization of speech is considered a means to provide description, self-questioning, 
and reflection through language (Flavell, Miller, & Miller, 1985).  Self-regulation has 
been defined as a response that serves to modify the probability of a later consequence 
related to the event responded to (Kanfer & Karoly, 1972).  Reconstitution is the ability 
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to create multiple novel complex alternative response chains in either language or motor 
activity (Milner, 1995).  Barkley later revised his model to include the following 
executive functioning abilities: self-monitoring, organization, planning, initiating and 
completing tasks on a timely basis, tracking and shifting tasks, and self-inhibition 
(Barkley, 2015).   
According to Brown’s theory, ADHD is related to deficits of executive 
functioning, specifically activation, focus, effort, emotion, memory, and action (2002).  
Activation refers to the ability to organize and prioritize, whereas focus refers to the 
ability to sustain attention during tasks.  Effort refers to the ability to regulate alertness 
and sustained effort.  Emotion refers to frustration management and emotional regulation.  
Memory refers to utilization of working memory and recall.  Finally, action refers to 
monitoring and self-regulation (Brown, 2002).   
Neuropsychological correlates of adult ADHD. 
 ADHD is conceived of by some as a dimensional disorder, meaning that 
symptoms are not based simply on the binary presence or absence of symptoms, but that 
symptoms and corollary problems exist on a continuum.  Symptoms may range from the 
mild, subclinical to severe ADHD, based on extremes of a continuum of inattentive 
and/or hyperactive-impulsive symptoms (Kern, Geier, Sykes, Geier, & Deth, 2015; 
Schneider et al., 2010; Stevenson et al., 2005).  Recent research has investigated 
neuropsychological substrates accounting for variability and symptom presentation in 
ADHD.  Specifically, symptoms are theorized to result from a breakdown in the top-
down control system, a breakdown in bottom-up capacity for attentional capture, or a 
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breakdown in top-down regulation of emotion (Nigg, 2015; Nigg, Blaskey, Huang-
Pollock, & Rappley, 2002).   
 A breakdown in the top-down control system presents as disturbance in executive 
functioning and response inhibition.  A breakdown in top-down emotional regulation is 
thought to present as increased impulsivity (Arnsten & Rubia, 2012; Shaw, Stringaris, 
Nigg, & Leibenluft, 2014).  Top-down processing deficits are thought to influence 
allocation of attention to emotionally arousing stimuli.  Some individuals may allocate 
increased attention to arousing stimuli, whereas others may allocate decreased attention, 
which can present as emotional lability or callousness, respectively (Arnsten & Rubia, 
2012; Polier, Vloet, & Herpertz‐Dahlmann, 2012; Shaw et al., 2014).  Finally, breakdown 
in regulation of negative emotionality is thought to correlate with disturbances in self-
concept and self-esteem (Nigg, 2015).  A breakdown in bottom-up attentional capture 
presents as diminished alertness, sometimes characterized as sluggish cognitive tempo.   
 Additionally, other potential neurobiological and neuropsychological explanations 
have been proposed, e.g., an abnormality in reward-related circuitry leading to decreased 
delay gradients and delay aversion (Sonuga-Barke, 2002).  Deficits in nonworking visual 
memory, working memory, attentional set shifting, and stop signal inhibition have been 
proposed (Nigg, Willcutt, Doyle, & Sonuga-Barke, 2005; Rhodes, Coghill, & Matthews, 
2004; Schachar, Mota, Logan, Tannock, & Klim, 2000; Smith, Taylor, Warner Rogers, 
Newman, & Rubia, 2002). 
 In past research, it has been suggested that ADHD symptoms may diminish over 
time, although some studies note that this may partly be a function of developmental 
changes and acquired coping strategies (Agnew-Blais, Seidman, & Buka, 2013; 
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Biederman, Mick, & Faraone, 2000; Faraone, Biederman, & Mick, 2006; Hill & 
Schoener, 1996; Ramsay, 2010a, 2010a).  Recent studies suggest, however, that the 
presentation of ADHD may change but not necessarily diminish (Biederman, Petty, 
Evans, Small, & Faraone, 2010; Turgay et al., 2012; Wilens, Biederman, & Spencer, 
2002).  In addition, the decline in symptoms of ADHD has been found to be greater in 
males than in females (Balint et al., 2009; Biederman et al., 2010).  Contradictory 
evidence suggests symptom persistence is greater in males than in females, however 
(Bauermeister et al., 2007).  As previously discussed, more recent evidence demonstrates 
that ADHD persists across the lifespan.  Thus, treatment for ADHD accounts for 
developmental challenges and their variation throughout the lifespan (Biederman et al., 
2010; Brod, Schmitt, Goodwin, Hodgkins, & Niebler, 2012; Turgay et al., 2012). 
Evidence indicates that ADHD is related to variations in neuropsychological, 
neurological, and behavioral domains.  As previously discussed, variations in bottom-up 
and top-down processing, reward system responsiveness, and executive functioning are 
proposed neuropsychological contributors to ADHD symptom presentation.  
Furthermore, ADHD is thought to persist across the lifespan as a function of such 
variations and neurological variations, which often present as variations in behavior and 
associated symptoms of ADHD.   
Neurological correlates of adult ADHD. 
 Structural neurological variations and their association with ADHD have been 
well documented among children and adults (Jadidian, Hurley, & Taber, 2015; Keune, 
Wiedemann, Schneidt, & Schönenberg, 2015; Krause, la Fougere, Krause, Ackenheil, & 
St H, 2005; Mohamed, Börger, Geuze, & van der Meere, 2015; Stevenson et al., 2005; 
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Swanson et al., 2000; Thissen et al., 2015; Tian et al., 2008; Yu-Feng et al., 2007).  
Functional variations have been observed in individuals with ADHD.  Many such 
variations are thought to relate to structural abnormalities associated with ADHD 
(Arnsten & Rubia, 2012; Kofler et al., 2014; Nigg et al., 2002).    
Genetic and phenotypical variations associated with ADHD. 
A growing body of evidence indicates that heritable, genetic risk factors 
significantly predict many neurological variations associated with ADHD (Daley, 2006; 
Franke, 2015; Jadidian et al., 2015; Keune et al., 2015; Mohamed et al., 2015, 2015; 
Stevenson et al., 2005; Thissen et al., 2015).  For example, individuals with ADHD are 
more likely to have phenotypical variations related to dopamine transportation, dopamine 
receptor expression, serotonin transportation, and norepinephrine transportation (Daley, 
2006; Kim et al., 2006; Kollins et al., 2008; Prince, Wilens, Spencer, & Biederman, 2015; 
Thissen et al., 2015; Wu, Xiao, Sun, Zou, & Zhu, 2012).  Also implicated among 
individuals with ADHD are higher rates of variations in the D4 dopamine receptor gene 
(Daley, 2006).  Response control has been associated with variations in dopamine 
transporter availability in individuals with ADHD, supporting the assertion that dopamine 
transportation and receptor expression are central to ADHD (Krause et al., 2005; 
Swanson et al., 2000; Volkow et al., 2007; Wu et al., 2012).  Moreover, evidence 
suggests that abnormalities in dopamine transportation in addition to functioning and 
reduced volumetry of the anterior cingulate cortex contribute to the symptom 
presentation associated with ADHD, specifically, deficits in reward anticipation, impulse 
control, and emotion regulation (Amico, Stauber, Koutsouleris, & Frodl, 2011; Brown et 
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al., 2010; Bush et al., 1999; Castellanos et al., 2008; Fallgatter et al., 2004; Seidman et 
al., 2006).   
Dopamine transportation and reception in the nucleus accumbens is thought to 
influence motivation and goal oriented behavior (Goto & Grace, 2005).  A recent study 
found that dopamine D2 receptor (D2R) postsynaptic expression enhancement relates to 
enhanced motivation in adult mice, supporting this assertion (Trifilieff et al., 2013).  
Moreover, a study of adult rats found that following an artificial increase in the 
postsynaptic expression of D2R, increased risk proneness and impulsive behavior were 
more likely to be expressed (Adriani et al., 2009). Theories of dopamine pathway 
variations in ADHD posit that reception and transportation of dopamine in the nucleus 
accumbens, including the ventral striatum, may account in part for motivational deficits 
noted in ADHD (Bédard et al., 2010; Goto & Grace, 2005; Ikemoto & Panksepp, 1999; 
Swanson et al., 2000; Wu et al., 2012).             
Structural neurological variations associated with ADHD. 
The steroid sulfatase axis (STS) has been associated with ADHD; polymorphisms 
in the STS gene were linked to a diagnosis of ADHD (Brookes et al., 2008, 2010; Davies 
et al., 2014).  A recent study examined the effect of pharmacological modulation of STS 
and found that modulation improved response control.  Though the STS has not been a 
subject of systematic study, it represents an important consideration in the study of 
ADHD neurology.   
Research indicates that differences in frontal brain asymmetry may relate to both 
depressive and ADHD symptoms (Avila, 2011; Jadidian et al., 2015; Keune et al., 2015).  
Positive asymmetry refers to increased activation in the left hemisphere relative to the 
13 
 
right hemisphere, whereas the opposite is true of negative asymmetry (Stevenson et al., 
2005).  Individuals with ADHD are more likely to have negative asymmetry, suggesting 
excessive behavioral approach tendencies (as opposed to a more cognitive style) and 
predisposition to depression (Keune et al., 2015; Mohamed et al., 2015; Stevenson et al., 
2005).  
In addition, evidence suggests that variations in the structure of the caudate 
nucleus play a role in deficiencies in procedural learning and executive functioning 
(Castellanos et al., 1994; Hynd et al., 1993; Volkow et al., 2007).  A recent study found 
that deficits in executive functioning could, in part, be attributable to deficits in simple 
processes or subexecutive functions, such as subvocal articulation or internal speech 
(Hale, Bookheimer, McGough, Phillips, & McCracken, 2007).   
Similarly, the cerebellum has been the subject of consideration, although it has 
not been the subject of systematic study.  Some evidence suggests that individuals with 
ADHD are more likely to have reductions in the volume of the cerebellum (Bledsoe, 
Semrud-Clikeman, & Pliszka, 2009; Carmona et al., 2005; Cortese et al., 2012; Emond, 
Joyal, & Poissant, 2009; Frodl & Skokauskas, 2012; Krain & Castellanos, 2006; Tiemeier 
et al., 2010; Valera, Faraone, Murray, & Seidman, 2007).    
Functional neurological variations associated with ADHD. 
Variations in baseline brain activity and oxygenation have been found in both 
children and adults with ADHD (Hale et al., 2007; Konrad & Eickhoff, 2010; Tian et al., 
2008; Yu-Feng et al., 2007). Specifically, individuals with ADHD were found to have 
decreased lateral prefrontal oxygenation during a working memory task, compared to 
non-ADHD peers (Auer, 2008; Ehlis, Bähne, Jacob, Herrmann, & Fallgatter, 2008; 
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Schecklmann et al., 2010).  A growing body of evidence suggests that difficulties with 
response inhibition and inefficient cognitive control are characteristic of ADHD symptom 
presentation, theorized to be the province of the frontal cortex (Boonstra, Kooij, 
Oosterlaan, Sergeant, & Buitelaar, 2010; Clark et al., 2007; King, Colla, Brass, Heuser, & 
von Cramon, 2007; Konishi et al., 1999; McLoughlin et al., 2009; Ridderinkhof, Van 
Den Wildenberg, Segalowitz, & Carter, 2004; Rubia, Smith, Brammer, & Taylor, 2003; 
Verbruggen & Logan, 2008).  Physical exercise has been found to alleviate difficulties 
with response inhibition and cognitive control and to increase oxygenation in the 
prefrontal cortex in individuals with ADHD (Archer & Garcia, 2014; Archer & 
Kostrzewa, 2012; Choi, Han, Kang, Jung, & Renshaw, 2015).  Similarly, medication for 
ADHD has been associated with increased blood flow and activation in the prefrontal 
cortex (Lee et al., 2005; Spalletta et al., 2001).  Moreover, recent evidence suggests that 
cognitive behavioral therapy (CBT) increases regional functional connectivity strength in 
the fronto-parietal network and cerebellum.  Increases in functional coupling between 
bilateral superior parietal gyrus were found to positively correlate with improvement in 
ADHD symptoms following CBT treatment (Wang et al., 2016).    
Recent fMRI studies show that dysregulation in alertness levels, such as enhanced 
resting state brain activity, disturbed regulation, and disturbed sleep, are associated with 
ADHD (Cortese, Konofal, & Lecendreux, 2008; Hale et al., 2007; Tian et al., 2008).  One 
such study suggested the hypocretin/orexin system, which is implicated in arousal, could 
contribute to the observed variations (Cortese et al., 2008). 
Electroencephalography (EEG) has been used to assess ADHD since the de novo 
device approval in 2013 (U.S. Food and Drug Administration, 2013).  Theta to beta ratio 
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(TBR) has been investigated as a potential biomarker for ADHD (Arns, Conners, & 
Kraemer, 2012; Loo & Arns, 2015; Snyder, Rugino, Hornig, & Stein, 2015).  The TBR is 
a ratio of slow-wave theta bands to the faster beta bands (Loo & Arns, 2015; Snyder et 
al., 2015).  EEG-indicated theta band activity is known to reflect cortical slowing or 
drowsiness, whereas beta band activity is often reflective of concentration and focused 
mental activity (Loo & Arns, 2015).  Increases in slow-wave activity and thus a higher 
TBR prior to psychopharmocological treatment have been found to be positively 
correlated with positive responses to stimulant medication (Arns, Heinrich, & Strehl, 
2014; Loo & Arns, 2015).  Evidence suggests that individuals with ADHD have greater 
levels of theta band waves relative to beta band waves than neurotypical individuals, 
although there is some contradictory evidence (Faraone, Bonvicini, & Scassellati, 2014; 
Lenartowicz & Loo, 2014; Øgrim, 2014).  However, replication of these findings has 
proven difficult (Loo & Arns, 2015; Saad, Kohn, Clarke, Lagopoulos, & Hermens, 2015).  
The cause is unknown, although one explanation for the increase in TBRs among non-
ADHD samples is increasing development and use of portable technology (Loo & Arns, 
2015).   
Finally, individuals with ADHD are more likely to experience sleep disturbances, 
which can exacerbate symptoms of ADHD and result in decreased sustained attention, 
working memory impairment, and reduced ability to perform tasks that require attention 
(Alhola, & Polo-Kantola, 2007; Kolb, & Whishaw, 2005; Schredl, Alm, & Sobanski, 
2007).  For both neurotypical individuals and those with ADHD, sleep disturbances and 
insomnia decrease attentional ability and working memory (Cortese et al., 2006; 
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DeCrescenzo, et al., 2015; Gruber et al., 2012; Hoban 2008; Schredl, Alm, & Sobanski, 
2007; Kooij et al., 2008).   
Behavioral correlates of adult ADHD. 
 Individuals with ADHD may exhibit differences in behavior from individuals 
without ADHD, especially prior to and during execution of tasks that require sustained 
attention and effort.  Some common examples include the tendency of individuals with 
ADHD to engage in more procrastination, aggressive confrontation, and impulsive 
decision making than others (Young, 2005).  As previously discussed, individuals with 
ADHD are often more focused on preparation for a task (i.e., preparing workspace, 
avoiding potential obstacles) than the task itself, due to negative asymmetry in the 
prefrontal cortex (Avila, 2011; Keune et al., 2015).  Thus, without appropriate planning, 
these individuals must rely on more reevaluation and adaptation during tasks than 
individuals without ADHD (Avila, 2011; Keune et al., 2015).  To compound matters, 
reevaluation and adaptation are some of the executive functions often lacking in 
individuals with ADHD.  However, the ability to reevaluate and adapt to a unique 
situation has been found to relate to coping ability in individuals with ADHD (Young, 
2005; Zametkin & Ernst, 1999).  Issues related to reduced self-control, difficulty 
planning, and problems processing the long-range consequences of a potential action are 
characteristic of ADHD and may produce negative outcomes in many important life 
domains, such as financial planning and maintaining physical health (Kessler et al., 2006; 
Ramsay, 2010a; Solanto, 2015; Young, 2005).  
 Research indicates that adults with ADHD are more likely to engage in 
dysfunctional health behaviors such as nicotine use, sedentary lifestyle, poor diet, and 
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lack of exercise than non-ADHD controls (Combs, Canu, Broman-Fulks, Rocheleau, & 
Nieman, 2015; Solanto, 2015; Young, 2005).  Individuals with ADHD are also at 
increased risk for psychoactive substance use disorders (Biederman et al., 1997; Wilens, 
Biederman, Spencer, & Frances, 1994).  Research suggests two potential reasons why 
ADHD and substance use disorder (SUD) may be related.  First, dopamine 
neurotransmission plays a central role in current models of ADHD and substance use 
models (Bédard et al., 2010; O’Hara et al., 1993; Ray et al., 2010).  Second, children of 
adults with SUD are more likely to develop psychopathology including ADHD 
(Biederman et al., 1992, 1997).  Given the aforementioned considerations, similarities in 
etiological origin may account for the relation of SUD to ADHD.      
Deficits in executive functioning are thought to be central to many symptoms 
characteristic of ADHD (Barkley, 1997; Brown, 2002).  As mentioned, Brown’s theory 
of ADHD posits that deficits in executive functioning, specifically activation, focus, 
memory, effort, emotion, and action are contributors to ADHD symptoms (2002). 
Alternately, Barkley’s revised model proposes that executive functioning includes self-
monitoring, organization, planning, initiating and completing tasks in a timely basis, 
tracking and shifting tasks, and self-inhibition (2015a).  Research seems to corroborate 
Barkley’s and Brown’s respective theories (Boonstra, Oosterlaan, Sergeant, & Buitelaar, 
n.d.; Hall et al., 1997; Solanto, 2015).   
Children with ADHD also frequently experience greater difficulty with 
motivation and effortful control (Dovis, Van der Oord, Huizenga, Wiers, & Prins, 2015).  
Deficits in working memory have been found in children with ADHD, as well (Kofler et 
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al., 2014).  Adults with ADHD experience heightened perceptions of stress, specifically 
when tasked with an activity with a high attentional demand (Combs et al., 2015).   
Motivation plays an important role in academic outcomes, and individuals with 
ADHD experience greater difficulty with motivation (Linnenbrink & Pintrich, 2002).  
Motivation has been found to relate to academic success among students with ADHD and 
has been a focus of recent research (Brim & Whitaker, 2000).  Research also suggests a 
relationship between ADHD and emotional regulation (Barkley, 1997; Brown, 2002; Hall 
et al., 1997; Solanto, 2015). 
Treatment of ADHD 
Cognitive distortions and stress have been associated with ADHD severity; the 
latter is generally operationalized as scores on psychometrically sound but subjective 
self-report measures (Mitchell et al., 2013; Roberts, 2015 Schmidt, Stark, Carlson, & 
Anthony 1998; Strohmeier, 2013).  Cognitive behavioral therapy (CBT; Beck 1976) has 
been empirically validated as a treatment for ADHD in child, adolescent, and adult 
populations (Canu & Wymbs, 2015; Knouse, 2015; Ramsay, 2010c; Ramsay & Rostain, 
2011).  CBT focuses upon the interplay between thoughts, emotions, and behaviors 
(Beck,1976, 2005).  Modifying cognitive distortions is a focal point of treatment for CBT 
of ADHD (Mitchell et al., 2013; Ramsay, 2010).  The origin of these distortions is 
thought to be distressing emotions related to functional impairments in attentional ability, 
motivation, impulse control, and memory.  According to Ramsay (2010), these 
impairments can lead to maladaptive compensatory strategies, such as avoidance of 
demanding tasks in the aforementioned areas.  This pattern can create and maintain 
maladaptive beliefs over time.  These maladaptive beliefs are thought to be further 
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strengthened by the related problematic behaviors (e.g., procrastination and avoidance) 
(Ramsay, 2010b).  During childhood, individuals with ADHD may receive negative 
feedback from others regarding their abilities, which may result in negative feelings 
regarding the self by adulthood. Such feelings often lead to negative thoughts, thus 
facilitating avoidance behavior and reducing motivation, exacerbating preexisting 
difficulties (Ljusberg & Brodin, 2007; Nelson, 2011; Tabassam & Grainger, 2002).  
Adults who hold inaccurate perceptions and interpretations of symptoms related to 
ADHD may attribute their difficulties to their own moral flaw or personality, which may 
facilitate further negative self-evaluation (Dan & Raz, 2012; Nelson, 2011; Tabassam & 
Grainger, 2002).  Adults with ADHD have higher levels of negative self-views and 
pessimism (Dan & Raz, 2012; Nelson, 2011; Ramsay, 2010c).   
CBT for ADHD addresses cognitive distortions and often incorporates 
psychoeducation to help the client understand the disorder, identify deficits and 
symptoms, and more effectively manage deficits and symptoms (Christner, Stewart, & 
Freeman, 2007; Ramsay, 2007; Young, 2002).  Psychological intervention for ADHD 
focuses on the adaptation of the surrounding environment to make accommodations that 
facilitate the achievement of success (Ramsay, 2010c; Young, 2002).  In addition, CBT 
for ADHD focuses on assisting the individual to develop skills necessary to achieve goals 
set in therapy and cope with associated deficits and symptoms (Canu & Wymbs, 2015; 
Ramsay, 2010c; Young, 2002, 2005).  A recent study supports these techniques and 
suggests that CBT increases regional functional connectivity strength in the fronto-
parietal network and cerebellum, the brain regions most often affected by medication 
(Wang et al., 2016).    
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Pharmacotherapy remains a common first-line treatment for ADHD (Brown & La 
Rosa, 2002; Dodson, 2005; Mészáros et al., 2009; Prince et al., 2015). Cognitive therapy 
combined with pharmacotherapy is regarded as the most efficacious treatment for ADHD 
in adults because the interventions target symptoms (Brown & La Rosa, 2002; Dodson, 
2005; Prince et al., 2015; Ramsay, 2010c; Rostain, Jensen, Connor, Miesle, & Faraone, 
2015), such as time management, organization, self-esteem, planning, and 
procrastination, that are apparently less amenable to treatment with medication (Brown & 
La Rosa, 2002; Dodson, 2005; Prince et al., 2015). 
Although evidence supports the efficacy of ADHD treatment, challenges in 
assessment and diagnosis of ADHD, such as variability in symptom presentation, 
symptom overlap with other disorders, and the prevalence of comorbid disorders, pose an 
inherent challenge to treatment (Goldstein & Ellison, 2002; Kennedy, 2007; 
Shemmassian, 2015).  To avoid misdiagnosis of ADHD, multitrait, multimethod 
assessment is widely considered an integral component of treatment (Jensen et al., 1999; 
Kennedy, 2007; Montano & Weisler, 2011; Shemmassian, 2015).  
Presentation of Behavioral and Neurological Variations in ADHD 
As previously discussed, behavioral, neuropsychological, and neurological 
variations contribute to observable and reported symptoms and deficits.  Inhibitory 
control is thought to relate to inattentive symptoms as well as to hyperactive and 
impulsive symptoms of ADHD (Clark et al., 2007; Lijffijt, Kenemans, Verbaten, & van 
Engeland, 2005; Ossmann & Mulligan, 2003; Quay, 1997; Schachar et al., 2000).   
Deficits in the inhibition of motor control are thought to relate to 
hyperactive/impulsive symptoms, whereas deficits in cognitive inhibition are thought to 
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relate to deficits related to inattention (Barkley, 1997; Clark et al., 2007; Ossmann & 
Mulligan, 2003; Quay, 1997).  Inhibitory control shares involvement with executive 
functioning processes and is thought to account in part for deficits in executive 
functioning.  For example, according to Brown’s model, focus is a component of 
executive functioning and requires cognitive inhibition of extraneous stimuli, and 
according to Barkley’s model, self-inhibition is considered a direct component of 
executive functioning (Barkley, 1997; Brown, 2002).  
Difficulty planning, reduced self-control, and difficulty processing the long-range 
consequences of a potential action are characteristic of ADHD (Kessler et al., 2006; 
Ramsay, 2010b; Solanto, 2015).  A recent study found that problems with self-concept 
predicted ADHD symptom severity (O’Brien, 2016).  In addition, increased likelihood of 
being diagnosed with an emotional disorder has been found among individuals with 
ADHD; men with ADHD are at risk (28%), whereas women are at even greater risk 
(49%) (Rasmussen & Levander, 2009).  The risk for suicidal ideation is increased for 
individuals with ADHD; specifically, one study found that whereas adolescent males are 
at risk (5.9%), adolescent females demonstrate greatly increased risk (17.9%) (Rucklidge 
& Tannock, 2001). 
ADHD and Psychiatric Comorbidities  
 ADHD is often comorbid with other psychiatric disorders, including depression, 
anxiety, bipolar disorder, oppositional defiance disorder, obsessive-compulsive disorder, 
and substance use disorders (Adler et al., 2007; Jensen, 2001; Kennedy, 2007; Kessler et 
al., 2006; Klassen, Katzman, & Chokka, 2010; Mayes et al., 2009; Murphy & Barkley, 
1996; Shemmassian, 2015; Young, Toone, & Tyson, 2003).  Comorbidity may be 
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explained as a long-standing history of functional impairment likely to result in low self-
esteem and demoralization, causing individuals to avoid certain situations, lack 
confidence, anticipate failure, and feel misunderstood (Ramsay, 2010a; Young et al., 
2003).  As discussed previously, individuals with ADHD often have deficits in executive 
functioning.  Deficits in executive functioning may negatively affect self-perceptions as a 
function of effects on effortful control and decision-making (Murray & Kochanska, 
2002).  An analysis from a national comorbidity survey indicated that among individuals 
diagnosed with ADHD, 38.3% were diagnosed with a co-occurring mood disorder, 
47.1% were diagnosed with a co-occurring anxiety disorder, 15.2% were diagnosed with 
a substance disorder, and 19.6% were diagnosed with an impulse control disorder 
(Kessler et al., 2006).  A reciprocal effect may also exist.  For example, whereas the 
prevalence of ADHD was estimated to be 6 to 8% of the overall population in 2006, the 
national comorbidity survey found that 14% of individuals with social phobia were 
diagnosed with ADHD, 25.4% of individuals who were diagnosed with drug dependence 
were also diagnosed with ADHD, 22.6% of individuals with dysthymia were also 
diagnosed with ADHD, and finally 21.2% of individuals with bipolar disorder were 
diagnosed with ADHD (Kessler et al., 2006; Polanczyk, Willcutt, Salum, Kieling, & 
Rohde, 2014).   
Assessment Techniques for ADHD 
The assessment of ADHD typically includes obtaining a complete history of 
symptoms and measures of academic, psychological, and neuropsychological functioning 
(Adler & Alperin, 2015; Kennedy, 2007; Shemmassian, 2015).  The format of these 
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measures may be self-report or behavioral, the latter including objective motion-based 
measurement.   
Self-report measurement used in the assessment of ADHD. 
Measurement of ADHD symptoms and related constructs through the use of self-
or other-report questionnaires offers the clinician information reflective of the 
individual’s perceived functioning beyond current behaviors and often within the scope 
of various contexts such as academic, social, and occupational functioning (Adler et al., 
2007; Erhardt et al., 1999; Jiang & Johnston, 2011; Kooij et al., 2008). Whereas self-
report questionnaires elicit information from the patients themselves, other-report 
questionnaires elicit information based upon observations of the patients’ family, friends, 
acquaintances, significant others, coworkers, or clinician (Kooij et al., 2008). In contrast 
to behavioral measures, described below, self-report measures of ADHD rely upon the 
reporter for information, which is filtered through subjective perceptions and 
interpretations (Erhardt et al., 1999; Kennedy, 2007; Kooij et al., 2008; Shemmassian, 
2015; Sumner, 2010; Teicher et al., 1996).  Some examples of widely accepted 
assessment tools include the Brown Attention−Activation Disorder Scale (BAADS), the 
Adult ADHD Self-Report Scale for Screening for Adult Attention-Deficit/Hyperactivity 
Disorder version 1.1 (ASRS v1.1), the Barkley Adult ADHD Scale Version IV 
(BAARS−IV) and the Conners’ Adult ADHD Rating Scale (CAARS) (Barkley, 2011a; 
Brown, 1992; Conners, Erhardt, & Sparrow, 1999; Kessler et al., 2006).  The BAADS 
consists of 40 self-report items that measure core symptoms of ADHD (Brown, 1992).  
The scale assesses five symptom clusters: sustained attention, activation, affect, effortful 
control, and memory (Adler, n.d.; Brown, 1992).  The CAARS is an ADHD scale 
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consisting of 66 self-report items that measure inattention, hyperactivity, impulsivity, and 
self-concept (Conners et al., 2002, 1999).  The ASRS-v1.1 is a six-item screening tool for 
adult ADHD for evaluating patients in a busy primary care setting (Hines, King, & Curry, 
2012; Kessler et al., 2005). The BAARS−IV is a 27-item screening tool for ADHD that 
incorporates measures of inattention, sluggish cognitive tempo, hyperactivity, and 
impulsivity (Barkley, 2011a). 
Clinical observation is also frequently used in ADHD assessment.  Clinical 
observation allows incorporation of behavioral observations, often made by a mental 
health professional (Goldstein & Ellison, 2002; Kennedy, 2007; Shemmassian, 2015).  
The addition of informant report measures offers further information regarding 
observable behavior outside of treatment (Goldstein & Ellison, 2002; Kennedy, 2007; 
Kooij et al., 2008; Shemmassian, 2015).   
Advantages of subjective/self-report assessment of ADHD. 
Self- and other-report instruments are widely used to measure ADHD symptoms 
and severity.  The benefits of this type of assessment are that it does not require special, 
costly equipment or technology, only training, a survey form, and a manual.  Thus, this 
method often requires less time, personnel, equipment, and expense (Goldstein & Ellison, 
2002; Hall et al., 2015; Kennedy, 2007; Kooij et al., 2008; Shemmassian, 2015).  Unlike 
objective assessment, subjective assessment is able to measure behaviors outside of the 
context of the therapy in the experiential context in the individual’s daily life (Kennedy, 
2007; Kooij et al., 2008). In addition, self-report questionnaires are capable of measuring 
constructs otherwise immeasurable via objective means.  Cognitive distortions, for 
example, can not be measured using objective assessment. 
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Limitations of self- and other-report assessment of ADHD.  
Self-report measures of ADHD are often limited in their ability to rule out 
explanations other than ADHD for the presenting problem and generally do not include 
assessment for other psychiatric disorders, trauma, or significant life events (Erhardt et 
al., 1999).   
Self- and other reports and even clinical observation are reactive measures and, 
therefore, reports may be subject to personal bias and the extent of executive functioning 
(Barkley, 1997; Kooij et al., 2008; Solanto, 2015).  Thus, ADHD patients completing 
self-report measures are likely influenced by cognitive distortions, often found in 
individuals with ADHD and related comorbidities, as well as by deficits in executive 
functioning, a hallmark of ADHD itself.  They may perceive the severity of their ADHD 
differently, based on these limitations (Kooij et al., 2008; Mitchell, Benson, Knouse, 
Kimbrel, & Anastopoulos, 2013; Ramsay, 2010c; C. Strohmeier, 2013).  Many 
difficulties and frustrations with ADHD occur publicly, for example (e.g., forgetting an 
appointment, difficulty managing tasks at work, not remembering a promise to a friend), 
and the resulting negative feedback may heighten perceived deficits.  In summary, 
answers from respondents to both self- and other reports are filtered through their 
subjective interpretations and perceptions (Erhardt et al., 1999; Kennedy, 2007; Kooij et 
al., 2008; Shemmassian, 2015; Sumner, 2010; Teicher et al., 1996).  Executive functions 
can be defined as self-directed actions of an individual used to self-regulate (Barkley, 
1997).    
For example, individuals with ADHD, and specifically with deficits in executive 
functioning, might value education highly, yet have difficulty motivating themselves to 
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apply extra effort and behave in a way that is congruent with their beliefs.  They might 
then report themselves to be more attentive in academic situations than they realistically 
tend to bem based on their beliefs about themselves, demonstrating a positive illusory 
bias. 
Objective measurement used in the assessment of ADHD. 
Objective measures of ADHD offer supplementary data to further inform ADHD 
assessment and provide information that may be less subject to influence by personal 
bias, cognitive distortions, or deficits in self-monitoring (Hall et al., 2015; Heiser et al., 
2004; Stein et al., 2016; Sumner, 2010; Teicher et al., 1996).  Continuous performance 
tasks (CPT) are often used as objective measures for ADHD.  Recently, some CPTs have 
incorporated motion-based measurement into their analysis (Edebol, Helldin, & 
Norlander, 2013; Heiser et al., 2004; Sumner, 2010; Teicher et al., 1996, 2008).  The 
incorporation of motion-based measurement into CPT assessments for ADHD provides 
additional information based on locomotor activity, which has been shown to relate to 
ADHD symptom severity and predict a diagnosis of ADHD (Epstein et al., 2003; Hall et 
al., 2015; Losier, McGrath, & Klein, 1996; Teicher et al., 2004; Teicher, Polcari, 
Fourligas, Vitaliano, & Navalta, 2012; Teicher et al., 2008).   
CPT measures include the Test of Variables of Attention (TOVA), the Gordon 
Diagnostic System (GDS), the Conner’s Continuous Performance Test (CCPT), and the 
Integrated Visual and Auditory Continuous Performance Task (IVA+CPT) (Conners et 
al., 2002; Edebol, Helldin, & Norlander, 2013; Gordon, McClure, & Aylward, 1996; Hall 
et al., 2015; Tinius, 2003).   
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Examples of motion-based continuous performance tasks (CPTs) include the 
Quotient ADHD System (formerly known as the McLean Motion and Attention System 
[MMAT] and prior to that as the Optical Tracking and Attention test [OPTAx]) and the 
Quantified Behavior (QB), each of which incorporates a measure of both attention and 
activity (head movement), in contrast to other CPTs (Edebol et al., 2013; Sumner, 2010).  
Although the TOVA, GDS, CCPT, and IVA+CPT seem to have good psychometric 
properties (e.g., test-retest reliability), they do not include a motion parameter, whereas 
the Quotient and QB Test do (Chae, Kim, & Noh, 2003; Hall et al., 2015; Heiser et al., 
2004; Kim et al., 2015; Losier, McGrath, & Klein, 1996; Matier, Halperin, Sharma, 
Newcorn, & Sathaye, 1992; Mayes et al., 2009; Wang et al., 2011). 
The QB Test is a motion-based CPT that requires the user to differentiate between 
letters that appear on a screen and is effective in differentiating individuals who meet 
criteria for ADHD from those who do not (Edebol et al., 2013; Hall et al., 2015).  
Similarly, the Quotient ADHD System is a motion-based CPT that has also been found to 
be more effective in differentiating individuals who meet the criteria for ADHD than 
CPTs that do not include a motion parameter (Hall et al., 2015; Jensen, 2001).   
The Quotient ADHD System is a computer-based, noninvasive, objective measure 
of ADHD that is usually completed in 15 to 20 minutes, in a single session (Sumner, 
2010).  The procedure includes a go/no-go task, wherein target stimuli (5-, 6-, and 7-
pointed stars) and nontarget stimuli (4-pointed stars) appear at a random position on a 
computer screen and in a random sequence for 200 ms each, at 2000 ms intervals at a 3:1 
ratio (Murillo et al., 2015; Teicher et al., 1996). Subjects are instructed to press a button 
with their right hand in response to target stimuli, which comprise about half of the 
28 
 
stimuli presented (Teicher et al., 1996). Variables measured for the go/no-go task are 
percent accuracy, percent omission errors (nonresponse to the occurrence of the target), 
percent commission errors (responses made when the target stimuli is not displayed), 
reaction time latency (response latency after the target occurrence), reaction time 
variability (intra-individual standard deviation [SD] of response times), and coefficient of 
variation (response time SD/mean latency) (Murillo et al., 2015; Teicher et al., 1996). 
The aforementioned variables provide analysis of response accuracy and response latency 
over the duration of the assessment, which previous studies have found to predict ADHD 
symptom severity (Epstein et al., 2003; Teicher et al., 1996, 2008; Wang et al., 2011).    
The Quotient ADHD System also measures locomotor activity using technology 
that detects positional stability in space (i.e., head movements), response accuracy, and 
response latency (Murillo et al., 2015; Sumner, 2010; Teicher et al., 2012).  The 
displacement of a spherical reflector secured with elastic bands on the forehead measures 
the movement variables.  Movement variables are head movement, which measures the 
average number of position changes greater than 1 mm over 4 intervals each 5 minutes in 
duration; head immobility duration, which is measured over each 5-minute interval; head 
displacement, which is the total distance traveled, in meters, on average during each 5-
minute interval; head area, referring to the two-dimensional space in which the reflector 
moved; head spatial complexity, referring to the fractal complexity of the movement 
path, with values of one or two; and head temporal scaling, indexing the frequency of 
movement (Murillo et al., 2015; Teicher et al., 1996).  In a recent meta-analysis, 
significant differences were found between ADHD and non-ADHD participants on 
measures of head movement, head displacement, head area, head temporal scaling, and 
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reaction time variability, suggesting the importance of the recent addition of motion 
variables to objective ADHD assessment (Losier et al., 1996). Moreover, assessment of 
motion-based variables provides measurement of hyperactive/impulsive motor activity 
and inattention; evidence suggests that this increases the test’s effectiveness with regard 
to differentiating individuals who meet criteria for ADHD from those who do not (Edebol 
et al., 2013; Hall et al., 2015).    
Advantages of objective assessment of ADHD. 
Objective assessment of ADHD severity measures observable behaviors such as 
the Quotient and thus, may be less reactive, given that it is thought to be less likely to be 
influenced by individual perceptions and biases than self-report instruments (Teicher et 
al., 2012).  Motion-based and continuous performance tasks used to measure ADHD 
offer precise measurements of locomotor activity and attentional impairment and allow 
signs and symptoms of specific difficulties to be isolated (Hall et al., 2015; Murillo et al., 
2015; Teicher et al., 1996, 2012).  
Research indicates that individuals with ADHD frequently engage in cognitive 
distortions, which could inform their perceptions, reduce accuracy, or increase ambiguity 
of their self-report of symptoms (Kooij et al., 2008; Mitchell et al., 2013; O’Brien, 2016; 
Rosenfield, 2004; Strohmeier, Rosenfield, DiTomasso, & Ramsay, n.d.).  
Disadvantages of objective assessment of ADHD. 
Computer-based objective assessment, such as the Quotient, measures observable 
behavior within an artificial environment, usually a treatment or research setting. Thus, 
important contextual influences on symptoms may not be present and, therefore, results 
may not capture a complete picture of real-world behavior, thereby reducing external 
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validity (Riccio & Reynolds, 2001). Additionally, computer-based objective assessment 
for ADHD is less useful for measuring daily or routine behavior outside the clinical 
setting and cannot measure past behavior (Erhardt et al., 1999; Hall et al., 2015; Heiser et 
al., 2004).  In addition, the findings of one study suggest that anxiety may play a role in 
performance on CPT tests (Epstein, Goldberg, Conners, & March, 1997). 
Multitrait multimethod assessment of ADHD.  
 Construct validity is based on integrated interpretation of evidence, and in 
construct validation, the assessment outcome is not directly equated with the construct it 
endeavors to measure, but rather is considered one indicator of the construct (Cronbach & 
Meehl, 1955; Messick, 1995).  Multitrait multimethod assessment of ADHD relies upon 
multiple measures to formulate a comprehensive view of related symptoms and 
functioning (Calderon & Ruben, 2008; Kennedy, 2007; Shemmassian, 2015). 
 Research demonstrates that ADHD varies widely in symptom presentation and 
symptom severity (Adler, n.d.; Adler & Alperin, 2015; Kennedy, 2007; Mayes et al., 
2009; Ramsay, 2010a; Shemmassian, 2015; Teicher et al., 2012).  Attention deficit-
hyperactivity disorder can present as symptoms related to inattention, symptoms related 
to hyperactivity/impulsivity, or as a combination of symptoms related to inattention and 
to hyperactivity/impulsivity (APA, 2013).  In addition to having multiple exclusive sets 
of symptom criteria, ADHD symptoms present with varying levels of severity among 
individuals with the disorder (Rasmussen & Levander, 2009). 
 To further complicate assessment, individuals with ADHD tend to engage in 
compensatory behaviors that alter the manifestation of ADHD symptoms.  (Erhardt et al., 
1999; Kooij et al., 2008; Young, 2005).  For example, one person may compensate for 
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inattention and distractibility by taking copious notes during conversations (Ramsay, 
2010b; Bradley M Rosenfield, Ramsay, & Rostain, 2008).  This compensatory strategy 
may vary in degree of acceptability, depending on context, e.g., in a business meeting 
versus in a casual conversation.  However, when asked about distractibility, such an 
individual may underreport or even deny inattention (on self-report) because the 
compensatory strategy has reduced the severity of the problem or has become so 
automatic that he or she may no longer be cognizant of it.  In such a case, a behavioral 
measure such as the Quotient may be a more valid and reliable measure of attention.  
On the other hand, the Quotient would be completely blind to early childhood history of 
symptoms, for which self- and other-report measures would be more appropriate.  
 Moreover, a major goal of ADHD assessment is not only to determine the 
presence or absence of ADHD, but also to identify comorbidities (Adler & Alperin, 2015; 
Barkley, 2015a; Kennedy, 2007).  Given the aforementioned considerations, the 
importance of the use of multiple methods across multiple traits is widely recognized to 
be necessary for accurate diagnosis (Adler & Alperin, 2015, 2015; Barkley, 2015a; 
Calderon & Ruben, 2008; Goldstein & Ellison, 2002; Kennedy, 2007; Shemmassian, 
2015).        
Purpose of the Study 
The purpose of this study was to determine whether ADHD symptom self-report 
predicts ADHD symptom severity, as measured by behavioral assessment.  Specifically, 
this study sought to determine if the Quotient ADHD System is a valid and reliable 
measure of ADHD symptoms and if the Quotient correlates with a widely accepted, 
psychometrically sound self-report ADHD measure, the CAARS.  A comparison of 
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objective and self-report measures of ADHD severity may help to clarify the nature of the 
relationship between these divergent measures of ADHD.  Improved understanding may 
inform assessment procedures and improve treatment planning related to adult ADHD.  
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Hypotheses 
 Accordingly, it was hypothesized that: 
H1: Self-report measurement of ADHD symptom severity (operationalized as the 
CAARS Inattention/Memory Problems, Hyperactivity/Restlessness, and 
Impulsivity/Emotional Lability scales) will predict and positively correlate with the 
Quotient ADHD System global scaled score metric. 
H2: Self-reported inattention/memory problems on the CAARS will predict 
behavioral measures of distractibility on the Quotient distracted metric, based on errors of 
omission. 
H3: Self-reported hyperactive/impulsive symptoms on the CAARS will predict 
impulsiveness Quotient scores on impulsiveness metric.  
H4: Hyperactivity/Restlessness and Impulsivity/Emotional Lability scale scores 
on the CAARS will predict behavioral impulsivity Quotient impulsive metric, based on 
errors of commission. 
H5: Hyperactivity/Restlessness, Impulsivity/Emotional Lability, and 
Inattention/Memory Problems scale scores on the CAARS will predict and behavioral 
hyperactivity on the Quotient Motion Global Scale. 
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Methods 
Research Design 
The study used a correlational research design to explore the relationship between 
self-report measurement of ADHD symptom and observable behavioral symptoms of 
ADHD.  Symptom severity was operationalized for the CAARS as the percentile rank 
derived from the T score associated with the total raw score of the ADHD Index and the 
Inattention/Memory Problems, Hyperactivity/Restlessness, and Impulsivity/Emotional 
Lability scales.  For the Quotient ADHD System, symptom severity was operationalized 
as the percentile rank, comprised of the global scaled score and metrics from the 
Attention State Summary report, including the Number of Shifts, Attentive, Impulsive, 
and Distracted; and Disengaged scales. 
Subjects 
 Archival data was gathered from 209 adults who participated in assessment and/or 
treatment at a university-based, outpatient clinic specializing in the treatment and 
research of adult ADHD.  The clinic is located in a large northeastern U.S. city.  Fees are 
mainly private payment and university-based insurance reimbursement.  The subjects 
included physician-, clinician- and self-referred patients.  Data was included in this study 
if the subject was between 18 and 88 years old and had completed the Conner’s Adult 
ADHD Rating Scale and the Quotient ADHD System assessment.  In addition, subjects 
had to have been diagnosed with ADHD – predominately inattentive type, ADHD – 
predominately hyperactive/impulsive type, or ADHD – combined type, based on a full 
developmental interview for relevant history and the DSM–5 diagnostic criteria (APA, 
2013).  Data for individuals with co-occurring substance abuse disorders and/or psychotic 
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disorders, as determined through the clinical interview process at intake, were excluded 
from the study.  Power analysis for multiple regression with three predictors was 
conducted in G*Power to ensure a sufficient sample size using an alpha of .05, a power 
of .80, and a medium effect size (f 2 = .015) (Faul, Erdfelder, Buchner, & Lang, 2009).  
Based on the aforementioned assumptions, the desired sample size was 77.  Data in this 
study was collected from 216 archived intake records to allow for incomplete records and 
to increase statistical power.  Seven records failed to meet the inclusion criteria and were 
excluded from the study; 209 records were used for the analysis (N = 209).   Data were 
analyzed using SPSS v. 25.0. 
Measures 
Quotient ADHD System. 
The Quotient ADHD System is an office-based continuous performance task 
developed to provide objective measurements of hyperactivity (ability to maintain 
positional stability), sustained attention, and impulsive inhibition, which correlate with 
severity and symptom presentation of ADHD and ADHD types with the use of similar 
motion-based assessment systems (Sumner 2010, Teicher et al., 2012).  When 
administered to an adult, the continuous performance task takes approximately 20 
minutes to complete (Murillo et al., 2015; Teicher et al., 2004).  Test-retest reliability for 
the Quotient ADHD System has been established at r = .95 for both accuracy and latency 
and r = .91 for the number of microevents (Murillo et al., 2015; Teicher et al., 2008).  
Concurrent validity, external validity, construct validity, and predictive validity have yet 
to be determined (Murillo et al., 2015).  The Motion Analysis report consists of the 
following metrics; immobility duration, movements, displacement, area, spatial 
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complexity, and temporal scaling.  Immobility duration refers to the average time sitting 
still and not moving; movements refers to the number of position changes greater than 1 
mm; displacement refers to the total distance moved by the marker; area refers to the 
total area covered by the markers path; spatial complexity refers to the complexity of the 
movement path; and temporal scaling refers to the frequency of movement over time.  
The Attention Response Analysis report consists of eight metrics: speed of responses for 
non-target hits, speed of responses for target hits, accuracy, omission errors, commission 
errors, latency, variability, and coefficient of variance (COV).  Speed of responses for 
nontarget hits refers to the time elapsed between the presentation of a nontarget stimulus 
and a response; speed of responses for target hits refers to the time elapsed between the 
presentation of a target stimuli and response; accuracy refers to the percentage of correct 
responses; omission errors refers to the percentage of missed targets; commission errors 
refers to the percentage of incorrect responses to nontargets; latency refers to the average 
time to respond correctly; variability refers to variation in response times to the correct 
target, and coefficient of variance (COV.) is a normalized measure of response time 
variation.  The Attention State report consists of the following metrics: number of shifts, 
attentive, impulsive, distracted, and disengaged.  Number of shifts is a measure of how 
frequently a change in behavioral states occurs over the course of a test (i.e., attentive to 
impulsive, attentive to distracted, attentive to disengaged, impulsive to distracted, 
impulsive to attentive, impulsive to disengaged, distracted to attentive, distracted to 
impulsive, distracted to disengaged, disengaged to attentive, disengaged to impulsive, 
disengaged to distracted); the total number of shifts in attention state may range from 0 to 
39.  The Attentive metric is comprised of the percentage of time wherein subjects 
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perform with high accuracy and consistent response latency; specifically, it is based on 
the combination of correct and incorrect target and nontarget responses and time to 
respond.  The Impulsive metric refers to the percentage of time wherein subjects produce 
an excessive number of commission errors or are too rapid in their responses.  The 
Distracted metric refers to the percentage of time wherein subjects make an excessive 
number of omission errors or are slow or inconsistent in their responses.  The Disengaged 
metric refers to the percentage of time in which subjects performed no better than chance.  
The Quotient testing report also yields a global scaled score, ranging from 0 to 10, which 
indicates the average of the Motion and Attention scaled scores and quantifies the 
patient’s overall performance.  Motion and Attention scaled scores are calculated from 
the six motion metrics and the 13 attention metrics. 
Conner’s Adult ADHD Rating Scale – Self-Report: Long Form 
(CAARS−S:L). 
 The CAARS−S:L is a 66-item self-report questionnaire designed to measure core 
symptoms of ADHD.  The items are organized into four scales (Inattention/Memory 
Problems, Hyperactivity/Restlessness, Impulsivity/Emotional Lability, and Problems 
With Self-Concept) (Conners et al., 1999).  The CAARS–S:L  also contains questions to 
assess DSM–IV ADHD inattentive symptoms, hyperactive-impulsive symptoms, and total 
symptoms. Further, the measure contains an ADHD index that incorporates these.  
 The CAARS is presented in a checklist format, and each item is rated from 0 (not 
at all, never) to 3 (very much, very frequently).  Individuals with a T score ≥ 65 on a 
given scale are considered to have clinically elevated symptoms in that area.  The greater 
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the number of scales that indicate clinically relevant elevations, the greater the likelihood 
of a clinically significant problem.       
 Analysis of the internal reliability of the CAARS scale yielded coefficient alphas 
for the four scales ranging from .86 to .92 for both males and females, suggesting that the 
the scales have excellent internal reliability (Erhardt et al., 1999).  Using Pearson 
product-moment correlations, the CAARS scales had the following test-retest 
correlations: .88 (p < .05) for Inattention, .90 (p < .05) for Hyperactivity/Restlessness, .80 
(p < .05) for Impulsivity/Emotional Lability, and .91 (p < .05) for Problems With Self-
Concept (Erhardt et al., 1999).  The CAARS was compared to the Wender Utah Rating 
Scale (WURS).  The WURS requires adults to retrospectively report childhood ADHD 
symptomatology, whereas the CAARS measures current symptoms.  However, the two 
scales are expected to relate because ADHD is now considered by many to be a 
developmental disorder that persists across the lifespan (Ramsay, 2010b; Ramsey & 
Rostain, 2005).  Based on the procedures for comparison originally outlined by Kessel 
and Zimmerman (1993), a recent study calculated efficiency statistics for the CAARS; 
specificity was 87%, sensitivity was 82%, negative predictive power was 83%, positive 
predictive power was 87%, false positive rate was 13%, false negative rate was 18%, 
kappa was 0.692; and the overall correct classification rate was 85% (Erhardt et al., 
1999).  These findings suggest that the CAARS does indeed represent a reliable and valid 
measure for ADHD.      
Procedure 
 Archival data was gathered from 216 clinical charts of participants at the 
aforementioned specialty clinic.  For charts meeting criteria for inclusion in the study, the 
39 
 
data relevant to the study was extracted and de-identified by the investigator, and each 
participant was assigned a unique identifier.  The de-identified data was transferred to a 
password-protected electronic database for data analysis.  Data consisted of the 
completed Quotient (global scaled score percentile rank) and three metrics of the 
Attention State results ( Attentive, Impulsive, and Distracted), the CAARS DSM–IV 
Hyperactive/Impulsive Symptom Count, and three CAARS scales (Memory Problems, 
Hyperactivity/Restlessness, and Impulsivity/Emotional Lability), which were interpreted 
based on the associated percentile rank to the T score.  
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Results 
 Statistical analyses were conducted to determine whether self-report measurement 
of ADHD symptom severity predicted observable measurement of ADHD symptom 
severity.  Additionally, the present study endeavored to determine if increased self-
reports of specific symptom subsets of ADHD predicted increased observable ADHD 
symptom severity.  Self-reported ADHD symptom severity was operationalized as three 
dimensions of ADHD symptom subsets (as measured by the CAARS).  These were a 
cognitive dimension (measuring inattention and memory), a behavioral dimension 
(hyperactivity and restlessness), finally a dimension assessing inhibition (impulsivity and 
emotional lability).  T- scores derived from normative data for the symptom subset 
measures were used as values for comparison.  Behavioral hyperactivity was 
operationalized as an analysis based on six motion metrics from the Quotient ADHD 
System (immobility duration, movements, displacement, area, spatial complexity, and 
temporal scaling), measured based on motion tracking readings from a sensor worn on 
the forehead while engaging in a continuous performance task.  These metrics were 
analyzed normatively to form a composite metric called the motion tracking scaled score.  
The value of this metric was used for comparison to the aforementioned self-report 
measures.  The motion-based metrics were also used in conjunction with 13 metrics of 
CPT performance (speed of responses for non-target hits, speed of responses for target 
hits, accuracy, omission errors, commission errors, latency, variability, coefficient of 
variation [COV], number of shifts, attentive, impulsive, distracted, and disengaged).  
These six motion-based metrics and 13 CPT performance metrics were analyzed 
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normatively to produce a global scaled score.  The value of the global scaled score was 
used to determine a value for the measurement of observable ADHD symptoms.  
 Table 1 provides the means, standard deviations, range, minimum, and maximum 
for the CAARS Inattention/Memory, Hyperactivity/Restlessness, and 
Impulsivity/Emotional Lability scales.  The Quotient ADHD System’s global scaled 
score and motion scaled score are presented in Table 1, as well.   
 
Table 1 
Summary Statistics for CAARS Symptom Subset Scale Scores and Quotient ADHD System 
Global and Motion-Based Scores 
Variable M SD Range Minimum Maximum 
CAARS Inattention/Memory 
Problems  
69.56 12.41 57.00 33.00 90.00 
CAARS Hyperactivity/Restlessness  
score 
57.02 11.37 54.00 28.00 82.00 
CAARS Impulsivity/Emotional 
Lability score 
57.95 12.04 59.00 31.00 90.00 
Quotient global scaled score  6.04 2.05 8.21 1.19 9.40 
Quotient motion scaled score  5.93 2.71 9.55 .11 9.66 
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Statistical Analyses 
Demographic analysis. 
 The sample consisted of 134 males and 75 females, with a mean age of 35 and an 
age range of 18 to 72.  Participants identified as 82.5% Caucasian, followed by 8.5% 
Other, 3.8% African American, 3.3% Hispanic, and 1.9% Asian American.  Participants 
had a mean education level of 15.8, years with a standard deviation of 2.46.  They had a 
minimum of 11 years and a maximum of 23 years of education.   
 It was hypothesized that self-report of the severity of ADHD symptoms, as 
measured by the CAARS, would predict the observable severity of ADHD symptoms, as 
measured by the Quotient ADHD System global scaled score.  We tested for 
independence of variables. Table 2 summarizes the correlations, means, and standard 
deviations.   
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Table 2 
Summary of Intercorrelations, Means, and Standard Deviations for Overall Score on the 
Quotient ADHD System and Symptom Subset Scales on the CAARS 
Measure 1 2 3 4 M SD 
1. Quotient ADHD 
System Global 
Scaled score 
-- .033 .268* .073 6.04 2.05 
2. CAARS Inattention/ 
Memory score 
.033 --    .341* .518* 69.56 12.41 
3. CAARS 
Hyperactivity/ 
Restlessness score 
.268* .341* --    .508* 57.02 11.37 
4. CAARS 
Impulsivity/ 
Emotional Lability 
score 
.073 .518* .508* -- 57.95 12.04 
*Correlation is significant at the 0.01 level (2-tailed) 
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Pearson product-moment correlations identified no significant correlation 
between self-reported severity of inattention/memory symptoms and observable ADHD 
severity (r = .033).  Additionally, no significant correlation was found between self-
reported severity of impulsivity/emotional lability symptoms and observable ADHD 
severity (r = .073).  However, a significant and positive correlation was found between 
self-reported severity of hyperactivity/restlessness symptoms and observable severity of 
ADHD symptoms (r = .268).  Given the lack of correlation for the other variables, a 
linear regression analysis was appropriate to determine if self-reported 
hyperactivity/restlessness would predict observable severity of ADHD symptoms (Field, 
2009).   
 Additional analyses of assumptions were accordingly conducted (Field, 2009).  
Standardized residuals were plotted against standardized predicted values, revealing that 
assumptions of homoscedasticity and linearity were met.  Specifically, the normality of 
the residuals was assessed through an examination of a normal probability plot (see 
Figure 1).  The normal probability plot, examining observed cumulative percentages to 
expected cumulative percentages, supported the assumption of normality.  
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Figure 1.  Standardized residuals and standardized predicted values for the Quotient 
ADHD System global scaled score. 
 
A linear regression analysis was conducted to identify whether self-reports of 
hyperactivity/restlessness would predict observable assessment scores of overall ADHD 
symptom severity.  The results revealed that increased hyperactivity/restlessness 
predicted increased observable symptoms of ADHD.   
The results of the linear regression analysis, as shown in Table 2, reveal a 
coefficient of correlation of .268 (R = .268), with a coefficient of determination of .072 
(R2 = .072).  The regression analysis revealed a significant regression, F(1, 208) = 
16.051, p = .000 indicating that hyperactivity/restlessness made a significant contribution 
to the global presentation of observable ADHD symptoms.  This indicates that 
approximately 7.2% of the Hyperactivity/Restlessness scale of the CAARS predicted the 
Quotient ADHD System global scaled score. 
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A Pearson product-moment correlation analysis was conducted to determine if 
self-reported inattention/memory problems significantly and positively correlated with 
behavioral measures of distractibility (errors of omission).  Results indicated a 
significantly positive relationship between inattention/memory and observable distracted 
attention state (r = .170, r2 = .029; p = .007).  Correlations, means, and standard 
deviations are presented in Table 3. 
 
Table 3 
Linear Regression Statistics for the Quotient ADHD System Global Scaled Score as the 
Dependent Variable 
Predictor 
Variable 
R R2 Adjusted 
R2 
SE of 
Estimate 
R2 
Change 
F Change df1 df2 Sig. F 
Change 
CAARS 
Hyperactivity/
Restlessness 
score 
.268 .072 .067 1.975 .072 16.051 1 208 .000 
 
A Pearson product-moment correlation was conducted to determine if increases in 
self-reported hyperactive/impulsive symptoms significantly positively and correlated 
with observable measurement of impulsiveness.  Results indicated no significant 
correlation between these measures (r = .108, p = .06).  Correlations, means, and standard 
deviations are presented in Table 4.  
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Table 4  
Intercorrelations, Means, and Standard Deviations for the Quotient ADHD System 
Distracted Metric and the CAARS Inattentive Memory Scale 
Measure 1 2 M SD 
1. Quotient ADHD System 
distracted metric score 
-- .170* 14.26 13.00 
2. CAARS Inattentive/Memory 
score 
.170* -- 69.56 12.42 
*Correlation is significant at the 0.01 level (2-tailed) 
 
Pearson product-moment correlational analyses were conducted to determine if 
hyperactivity/restlessness and impulsivity/emotional lability would correlate with 
behavioral impulsivity (errors of commission).  There was not a significant positive 
correlation (r = .010, p = .444) between observable measurement of impulsivity and self-
report measurement of impulsivity/emotional lability.  Moreover, observable 
measurement of impulsivity and self-report measurement of hyperactive/restlessness did 
not have a significant positive correlation (r = .065, p = .174).  A significant correlation 
was found between self-report measurement of impulsivity/emotional lability and 
hyperactivity/restlessness, however (r = .508, r2 = .258 p = .000).  Table 5 summarizes 
the correlations, means, and standard deviations for hyperactivity/impulsivity, 
impulsivity/emotional lability and behavioral impulsivity.   
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Table 5 
Intercorrelations, Means, and Standard Deviations for the Quotient ADHD System 
Impulsive Metric and the CAARS Hyperactive/Impulsive Symptom Scores 
Measure 1 2 M SD 
1. Quotient ADHD System 
impulsive metric  
-- .108 43.40 22.25 
2. CAARS Hyperactive/ 
Impulsive Symptoms 
score 
.108 -- 60.77 14.33 
 
To examine whether scores on scales of hyperactivity/restlessness, 
impulsivity/emotional lability, and inattention/memory problems would predict 
observable behavioral hyperactivity Pearson correlation analyses and linear regression 
analysis were conducted.  
As Table 6 shows, the only significant and positive correlation found was 
between the self-reported severity of hyperactivity/restlessness symptoms and observable 
behavioral hyperactivity (r = .231, r2 = .053; p = .001).  Additional significant and 
positive correlations were found within self-report measures of ADHD symptom subsets.  
Specifically, a significant positive correlation was found between self-report measures of 
inattention/memory and hyperactivity/restlessness (r = .341, r2 = .116; p = .000).  A 
significant positive correlation was also found between self-report measures of 
inattention/memory and impulsivity/emotional lability (r = .518, r2 = .268; p = .000).  
Finally, a significant positive correlation was found between self-report measures of 
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hyperactivity/restlessness and impulsivity/emotional lability (r = .508, r2 = .258; p = 
.000).  Given the aforementioned considerations, linear regression analysis was necessary 
only to determine if self-reported hyperactivity/restlessness would predict observable 
severity of ADHD symptoms.  Tests of assumptions and multiple linear regression were 
met.  Table 6 summarizes the correlations, means, and standard deviations for self-
reported hyperactivity/restlessness symptoms and observable behavioral hyperactivity. 
 
Table 6 
Intercorrelations, Means, and Standard Deviations for the Quotient ADHD System 
Impulsive Metric and the CAARS Impulsivity/Emotional Lability and 
Hyperactive/Restlessness Symptom Scores  
Measure 1  2 3 M SD 
Quotient impulsive metric -- .010 .065 43.40 22.25 
CAARS Impulsivity/Emotional 
Lability score 
.065 -- .508* 57.95 12.04 
CAARS Hyperactive/Restlessness 
score 
.010 .508* -- 57.02 11.37 
*Correlation is significant at the 0.01 level 
 
Standardized residuals were plotted against standardized predicted values, 
revealing that assumptions of homoscedasticity and linearity were met.  The normality of 
the residuals was tested through an examination of a normal probability plot (see Figure 
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2).  The normal probability plot examining observed cumulative percentages to expected 
cumulative percentages supported the assumption of normality.   
 
Figure 2. Standardized residuals and standardized predicted values for the Quotient 
ADHD System global scaled score. 
 
A linear regression determined that hyperactivity/restlessness predicted increased 
behavioral hyperactivity.  As shown in Table 7, the results of the simple regression 
analysis revealed a coefficient of correlation of .231 (R = .231), with a coefficient of 
determination of .053 (R2 = .053); minimal shrinkage was shown with the adjusted 
coefficient of determination (R2 = .049).  The regression analysis revealed a significant 
regression F(1, 208) = 11.796, p = .001 indicating that the CAARS 
Hyperactivity/Restlessness scale explained almost 5% of observable symptoms of 
behavioral hyperactivity on the Quotient ADHD System. 
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Table 7 
Summary of Intercorrelations, Means, and Standard Deviations for the Motion Scaled 
Score on the Quotient ADHD System and Symptom Subset Scales on the CAARS 
 1 2 3 4 M SD 
Quotient ADHD 
System motion 
scaled score  
-- -.045 .231* -.004 5.93 2.71 
CAARS Inattention/ 
Memory score  
-.045 -- .341* .518* 69.56 12.41 
CAARS 
Hyperactivity/ 
Restlessness score 
.231* .341* -- .508* 57.02 11.37 
CAARS Impulsivity/ 
Emotional 
Lability score 
-.004 .518* .508* -- 57.95 12.04 
*Correlation is significant at the 0.01 level 
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Table 8 
Summary of Linear Regression Statistics for the Quotient ADHD System Motion Scaled 
Score as the Dependent Variable  
Predictor 
Variable 
R R2 Adjusted 
R2 
SE of 
Estimate 
R2 
Change 
F Change df1 df2 Sig. F 
Change 
Hyperactivity/ 
Restlessness 
(CAARS) 
score 
.231 .053 .049 2.645 .049 11.796 1 209 .001 
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Discussion 
 This study examined the relationship between self-reported measurement of 
ADHD symptom severity, as measured by the Conner’s Adult ADHD Rating Scale 
(CAARS), and observable measurement of ADHD symptom severity, as measured by the 
Quotient ADHD System.  Given previous research supporting a relationship between 
self-report measurement of ADHD symptom severity and motion-based ADHD 
assessment, similar to the Quotient ADHD System, it was hypothesized that self-report 
measurement of ADHD symptom severity would predict motion-based behavioral 
measurement of ADHD symptom severity (Hall et al., 2015; Losier et al., 1996; Riccio & 
Reynolds, 2001; Teicher et al., 1996). 
 A comprehensive search of Google Scholar, PsychInfo, and EBSCO databases 
failed to find a single study investigating the validity and clinical utility of the Quotient 
ADHD System in an adult ADHD population, specifically as a means of supplemental 
diagnostic assessment for adults with ADHD.  However, some studies identified the 
sensitivity of the Quotient ADHD System to medication effects in children with ADHD 
(Heiser et al., 2004; Losier et al., 1996).  In addition, CPT derived motion-based 
assessments, including the OptaX system (past version of the Quotient ADHD System) 
and the Test of Variables of Attention (TOVA) have shown sensitivity to ADHD 
symptoms in children (Sumner, 2010; Teicher et al., 2008).  The QB Test was also found 
to be sensitive to ADHD in adults, but lacking in specificity to ADHD subtypes (Edebol 
et al., 2013; Lis et al., 2010).  Therefore, the present study endeavored to identify 
empirical support for the Quotient in the assessment of adults with ADHD and to inform 
the clinical utility of this ADHD CPT System.   
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Observable and Self-Report Measures of ADHD Symptom Severity 
The self-reported severity of hyperactive/restlessness symptoms, as measured by 
self-report on the CAARS, predicted 7.2 % of the variance in observable global scaled 
scores on the Quotient.  However, no significant relationship was identified between self-
reported inattention/memory symptoms (CAARS) and the global scaled score (Quotient 
ADHD System).  Moreover, no relationship was found between self-reported symptoms 
of impulsivity/emotional lability (CAARS) and the global scaled score (Quotient).  These 
findings suggest that Quotient measurement of observable symptoms of ADHD severity 
is sensitive to hyperactivity and restlessness, although possibly less sensitive to 
symptoms of ADHD related to inattention, memory, emotional lability, and 
impulsiveness (CAARS).   
This study also found that symptoms related to inattention and memory (as 
measured by the Inattention/Memory scale on the CAARS) accounted for 2.9% of the 
variance in observable.  Finally, hyperactivity and restlessness (as measured by the 
Hyperactivity/Restlessness scale on the CAARS) accounted for 5.3% of the variance in 
observable behavioral hyperactivity (as measured by the motion scaled score on the 
Quotient ADHD System).   
Implications 
Previous studies of motion-based continuous performance tasks have found that 
these measurements are sensitive to ADHD in children.  This may be explained by the 
current understanding of ADHD and recent findings, which suggest decreased motor 
activity with age and frequent reduction in hyperactivity and observable restlessness into 
adulthood (Turgay et al., 2012; Wilens et al., 2002).   
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Inattention and errors of omission. 
The current study found that CAARS self-reported inattention/memory shared a 
significant positive correlation with observable measurement of distraction, as measured 
by the Quotient ADHD System.  Past literature suggests that CPTs are sensitive to adult 
groups with a diagnosis of ADHD, but does not address specific subtypes of ADHD 
(Riccio & Reynolds, 2001; Teicher et al., 2008).  CPT performance tasks require 
sustained attention to a task.  Individuals with inattentive symptoms of ADHD have 
difficulty with such tasks.  Thus, lapses in attention or reduced attention may offer an 
explanation for increased errors of omission.  From a clinical perspective, further 
exploration of this potential connection could inform assessment of the ADHD − 
predominately inattentive type because CPT assessment could offer quantification of 
inattentive symptoms, as well as information on the specific presentation of these deficits.     
Identification of an association between ADHD symptom severity, as measured 
by self-report and ADHD symptom severity, as measured by motion-based assessment, 
contains several implications from a clinical standpoint.  Specifically, assessment of 
observable behavior circumvents the issues inherent with self-report measures, which are 
affected by reporting biases, a well-documented concern among individuals with ADHD 
(Adler et al., 2007; Erhardt et al., 1999; Knouse et al., 2005; Kooij et al., 2008; Nelson, 
2011; Prevatt et al., 2011).  CBT for adult ADHD has gained increasing support in recent 
years (Canu & Wymbs, 2015; Ramsay, 2010c, 2012; Ramsay & Rostain, 2011).  
Moreover, the use of multimodal, multidimensional, and contextually appropriate 
diagnostic assessment is recommended in assessing ADHD, and assessment of 
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observable behaviors contributes to a comprehensive assessment (Barkley, Knouse, & 
Murphy, 2011; Calderon & Ruben, 2008; Kennedy, 2007).   
Hyperactivity, impulsivity, and errors of commission. 
The current study found that no significant relationship existed between self-
report of hyperactive/impulsive symptoms (as measured by the CAARS) and observable 
measurement of impulsivity using errors of commission (as measured by the Quotient 
ADHD System).  The Quotient ADHD System determines the Impulsive metric based 
upon the frequency of errors of commission (the participant enters an incorrect answer in 
a limited time).  Although the metric attempts to capture the essence of impulsivity 
(action without thinking), no relationship was found between self-reported and 
observable measures of impulsivity.  Adults with ADHD have difficulty in self-
management, including organization, planning, initiating and completing tasks on a 
timely basis, tracking and shifting tasks, self-monitoring, and self-inhibition.  In the 
aggregate, these are executive functions (EFs), which are those self-directed actions 
needed to choose goals and to create, enact, and sustain actions toward those goals 
(Barkley, 1997; Ramsay, 2010b; Solanto, 2015). This difficulty in self-regulation 
typically results in reduced productivity, inefficiency, missed deadlines, poor planning, 
careless errors, and losing and forgetting things because of disorganization.  In some 
cases, reduced inhibitory control may also lead to emotional dysregulation and 
inappropriate verbal and/or physical behavior in interpersonal interactions. Over the 
lifetime of the individual, these difficulties contribute to failure to achieve goals 
personally, academically, and occupationally.  These failures, in turn, likely contribute to 
the high rates of anxiety and depression in adults with ADHD (Brown, 2002; Solanto, 
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2015b; Swanson, 2003).  Thus, individuals with ADHD may not exhibit observable 
inhibitory control deficits, given the lack of extraneous stimuli or demand on executive 
functioning during the continuous performance task offered by the Quotient ADHD 
System.  
Although these findings are surprising, they may be related to the characteristics 
of sample, which consisted of individuals who were more of a higher SES and higher 
functioning than the general ADHD population.  High levels of functioning, advancing 
through college, and maintaining productive and even higher paying employment may 
require the ability to inhibit errors of commission that are detectable by the Quotient. 
This finding deserves additional investigation and replication of the research.   
Discrepancy between self-report and CPT measured impulsivity. 
No significant relationship was found between self-reported 
hyperactivity/restlessness (as measured by the CAARS) and observable measurement of 
impulsivity (as measured by the Quotient ADHD System).  No significant positive 
relationship was found between self-reported impulsivity/emotional lability (as measured 
by the CAARS) and observable impulsivity (as measured by the Quotient ADHD 
System).  Previous literature suggests a connection between self-reports of ADHD and 
observable reports of impulsive symptoms within a CPT task when assessing children 
(Heiser et al., 2004; Teicher et al., 2008).  No relationship was found using the Quotient 
ADHD System Impulsive metric and the Impulsivity/Emotional Lability scale of the 
CAARS in the sample of adult participants in the present study.  The discrepancy may be 
explained by the changes in executive functioning ability developmentally from 
childhood to adulthood, as well as changes in coping strategies for deficits in executive 
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functioning from childhood to adulthood (Boonstra et al., n.d.; Fischer, Barkley, 
Smallish, & Fletcher, 2005; Wilens et al., 2002; Young, 2005).  Lack of significance here 
may also indicate that the two measures assess distinct manifestations of impulsivity.  
Specifically, the Quotient ADHD System motion metrics may indicate a manifestation of 
impulsivity that is underrepresented on self-report measures such as the CAARS due to 
lack of self-awareness.  Specifically, the CAARS requires self-awareness, whereas the 
Quotient ADHD System does not.     
Self-reported and behavioral hyperactivity.  
The present study found that self-reported hyperactivity/restlessness (as measured 
by the CAARS) predicted observable measurement of behavioral hyperactivity (as 
measured by the motion scaled score of the Quotient ADHD System).  In contrast, no 
significant relationship was found between self-report measures of inattention/memory 
(as measured by the CAARS) and observable measurements of behavioral hyperactivity.  
Furthermore, no significant relationship was found between self-reported 
impulsivity/emotional lability and observable behavioral hyperactivity (as measured by 
the motion scaled score of the Quotient ADHD System).   
The findings suggest that observable assessment of behavioral hyperactivity using 
the Quotient may be sensitive to hyperactive traits associated with ADHD.  This is 
supported by the predictive relationship between a widely utilized self-report 
measurement of ADHD symptoms and subsets, including hyperactivity/restlessness (the 
CAARS Hyperactivity/Restlessness Scale), and motion-based measurement of behavioral 
hyperactivity (motion scaled score on the Quotient ADHD System).  These findings 
suggest that increased behavioral hyperactivity (as measured by the Quotient ADHD 
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System) is most directly influenced by symptoms of hyperactivity/restlessness.  In 
addition, these findings suggest that motion-based measurement may not capture 
symptoms related to inattention/memory or impulsivity/emotional lability (as measured 
by the CAARS).  This shows good sensitivity, as well as convergent and discriminant 
validity of the Quotient motion scaled score. 
 The present study addresses a concern among clinicians as to whether to include 
objective assessment of ADHD and the extent to which it should inform case 
conceptualization and diagnosis.   
Limitations 
The current study used archival data, and therefore no direct behavioral 
observation interview and assessment were conducted.  With the exception of the 
Quotient and reports from collaterals, the majority of the data collected for the present 
study was gathered from self-report inventories.  Challenges to validity inherent in self-
report assessment create additional limitations.  In addition, the CAARS–S:L  measures 
ADHD in accordance with the DSM–IV (Conners et al., 1999) and has not yet been 
updated for the DSM–5.  Moreover, results may have been impacted by the fact that 
individuals with ADHD have been shown to have lower self-awareness and may 
underreport their symptoms, as previously discussed (Barkley et al., 2011; Jiang & 
Johnston, 2011; Kooij et al., 2008; Nelson, 2011).  
Generalizability of the present study’s findings are limited by characteristics of 
the sample, which consisted of individuals seeking assessment for ADHD at a university-
based outpatient adult ADHD specialty clinic in a large northeastern city.  Subjects were 
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high functioning individuals with the financial means to seek assessment and decidedly 
higher than average educational levels.   
Future Directions 
  Future studies should investigate in greater detail the value of objective 
assessment of ADHD, the extent to which it relates to ADHD symptom severity, and its 
relationship to specific subsets of ADHD symptoms (e.g., inattentiveness and 
impulsivity/hyperactivity).   
 Additional investigation as to whether specific scales within the CAARS predict 
ADHD symptom severity, as measured by motion-based assessment, may provide 
additional information that may further improve assessment and treatment planning.  
Investigation of the clinical utility of observable measures of symptom presentation may 
address this concern.  Moreover, future researchers may wish to compare the Quotient 
ADHD System to self-report assessments for ADHD that examine executive functioning 
directly, such as the Barkley Deficits in Executive Functioning Scale (Barkley 2011b).  
Finally, some results may be attributable to extraneous additional factors, such as 
distraction during testing, ADHD medication, and previous treatment.  The extent to 
which such factors influence outcomes may merit future investigation, as well. 
  
61 
 
References 
Adler, L. (n.d.). Diagnosis and Treatment Issues In Adult ADHD. Retrieved from 
http://www.villageofowego.com/pagezonesiteresources/rx-press2010-01-
04/Resources/file/Adler_Gasbarro_article.pdf 
Adler, L. A., & Alperin, S. (2015). Diagnosing ADHD in adults in the primary care 
setting. In R. A. Barkley & R. A. (Ed) Barkley (Eds.), Attention-deficit 
hyperactivity disorder: A handbook for diagnosis and treatment (4th ed.). (pp. 
501–509). New York, NY, US: Guilford Press. Retrieved from 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=psyh&AN=2014-57877-020&site=eds-live&scope=site 
Adler, L. A., Faraone, S. V., Spencer, T. J., Michelson, D., Reimherr, F. W., Glatt, S. J., 
… Biederman, J. (2007). The reliability and validity of self and investigator 
ratings of ADHD in adults. Journal of Attention Disorders. 
Adriani, W., Boyer, F., Gioiosa, L., Macri, S., Dreyer, J.-L., & Laviola, G. (2009). 
Increased impulsive behavior and risk proneness following lentivirus-mediated 
dopamine transporter over-expression in rats’ nucleus accumbens. Neuroscience, 
159(1), 47–58. 
Agnew-Blais, J., Seidman, L., & Buka, S. (2013). Adult ADHD: persistence, symptom 
profile and demographic characteristics. Comprehensive Psychiatry, 1(54), e1. 
American Psychiatric Association. (1980). DSM−III−R: Diagnostic and statistical 
manual of mental disorders. American Psychiatric Association. 
American Psychiatric Association. (1987). Diagnostic and statistical manual of mental 
disorders (DSM–III–R). Washington, DC: American Psychiatric Association. 
62 
 
Amico, F., Stauber, J., Koutsouleris, N., & Frodl, T. (2011). Anterior cingulate cortex 
gray matter abnormalities in adults with attention deficit hyperactivity disorder: a 
voxel-based morphometry study. Psychiatry Research: Neuroimaging, 191(1), 
31–35. 
Archer, T., & Garcia, D. (2014). Physical exercise improves cognition and health in 
ADHD. Journal of Novel Physiotherapies, 2014. 
Archer, T., & Kostrzewa, R. M. (2012). Physical exercise alleviates ADHD symptoms: 
regional deficits and development trajectory. Neurotoxicity Research, 21(2), 195–
209. 
Arns, M., Conners, C. K., & Kraemer, H. C. (2012). A decade of EEG theta/beta ratio 
research in ADHD: a meta-analysis. Journal of Attention Disorders, 
1087054712460087. 
Arns, M., Heinrich, H., & Strehl, U. (2014). Evaluation of neurofeedback in ADHD: the 
long and winding road. Biological Psychology, 95, 108–115. 
Arnsten, A. F., & Rubia, K. (2012). Neurobiological circuits regulating attention, 
cognitive control, motivation, and emotion: disruptions in neurodevelopmental 
psychiatric disorders. Journal of the American Academy of Child & Adolescent 
Psychiatry, 51(4), 356–367. 
Auer, D. P. (2008). Spontaneous low-frequency blood oxygenation level-dependent 
fluctuations and functional connectivity analysis of the ‘resting’brain. Magnetic 
Resonance Imaging, 26(7), 1055–1064. 
63 
 
Avila, R. (2011). The Relationships Between Frontal Alpha Asymmetry, Mood, and 
Emotional Memory. Graduate Theses and Dissertations. Retrieved from 
http://scholarcommons.usf.edu/etd/2992 
Balint, S., Czobor, P., Komlosi, S., Meszaros, A., Simon, V., & Bitter, I. (2009). 
Attention deficit hyperactivity disorder (ADHD): gender-and age-related 
differences in neurocognition. Psychological Medicine, 39(08), 1337–1345. 
Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: 
constructing a unifying theory of ADHD. Psychological Bulletin, 121(1), 65. 
Barkley, R. A. (2011a). Barkley Adult ADHD Rating Scale-IV (BAARS-IV). Guilford 
Press. 
Barkley, R. A. (2011b). Barkley deficits in executive functioning scale (BDEFS for 
adults). New York: Guilford Press. 
Barkley, R. A. (2015). Attention-deficit hyperactivity disorder: A handbook for diagnosis 
and treatment (4th ed.). (R. A. Barkley, Ed.). New York, NY, US: Guilford Press. 
Retrieved from 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=psyh&AN=2014-57877-000&site=eds-live&scope=site 
Barkley, R. A., Knouse, L. E., & Murphy, K. R. (2011). Correspondence and disparity in 
the self-and other ratings of current and childhood ADHD symptoms and 
impairment in adults with ADHD. Psychological Assessment, 23(2), 437. 
Bauermeister, J. J., Shrout, P. E., Chávez, L., Rubio‐Stipec, M., Ramírez, R., Padilla, L., 
… Canino, G. (2007). ADHD and gender: are risks and sequela of ADHD the 
64 
 
same for boys and girls? Journal of Child Psychology and Psychiatry, 48(8), 831–
839. 
Bédard, A.-C., Schulz, K. P., Cook, E. H., Fan, J., Clerkin, S. M., Ivanov, I., … Newcorn, 
J. H. (2010). Dopamine transporter gene variation modulates activation of 
striatum in youth with ADHD. Neuroimage, 53(3), 935–942. 
Biederman, J., Faraone, S. V., Keenan, K., Benjamin, J., Krifcher, B., Moore, C., … 
Steingard, R. (1992). Further evidence for family-genetic risk factors in attention 
deficit hyperactivity disorder: Patterns of comorbidity in probands and relatives in 
psychiatrically and pediatrically referred samples. Archives of General 
Psychiatry, 49(9), 728–738. 
Biederman, J., Mick, E., & Faraone, S. V. (2000). Age-dependent decline of symptoms of 
attention deficit hyperactivity disorder: impact of remission definition and 
symptom type. American Journal of Psychiatry, 157(5), 816–818. 
Biederman, J., Petty, C. R., Evans, M., Small, J., & Faraone, S. V. (2010). How persistent 
is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry 
Research, 177(3), 299–304. 
Biederman, J., Wilens, T., Mick, E., Faraone, S. V., Weber, W., Curtis, S., … Soriano, J. 
(1997). Is ADHD a risk factor for psychoactive substance use disorders? Findings 
from a four-year prospective follow-up study. Journal of the American Academy 
of Child & Adolescent Psychiatry, 36(1), 21–29. 
Bledsoe, J., Semrud-Clikeman, M., & Pliszka, S. R. (2009). A magnetic resonance 
imaging study of the cerebellar vermis in chronically treated and treatment-naive 
65 
 
children with attention-deficit/hyperactivity disorder combined type. Biological 
Psychiatry, 65(7), 620–624. 
Boonstra, A. M., Kooij, J., Oosterlaan, J., Sergeant, J. A., & Buitelaar, J. K. (2010). To 
act or not to act, that’s the problem: Primarily inhibition difficulties in adult 
ADHD. Neuropsychology, 24(2), 209. 
Boonstra, A. M., Oosterlaan, J., Sergeant, J. A., & Buitelaar, J. K. (n.d.). Executive 
functioning in adult ADHD: a meta-analytic review. 
Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of 
Psychiatry, 94(3), 577–585. 
Brim, S. A., & Whitaker, D. P. (2000). Motivation and students with attention deficit 
hyperactivity disorder. Preventing School Failure: Alternative Education for 
Children and Youth, 44(2), 57–60. 
Brod, M., Schmitt, E., Goodwin, M., Hodgkins, P., & Niebler, G. (2012). ADHD burden 
of illness in older adults: a life course perspective. Quality of Life Research, 
21(5), 795–799. 
Brookes, K., Hawi, Z., Kirley, A., Barry, E., Gill, M., & Kent, L. (2008). Association of 
the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. 
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 
147(8), 1531–1535. 
Brookes, K., Hawi, Z., Park, J., Scott, S., Gill, M., & Kent, L. (2010). Polymorphisms of 
the steroid sulfatase (STS) gene are associated with attention deficit hyperactivity 
disorder and influence brain tissue mRNA expression. American Journal of 
Medical Genetics Part B: Neuropsychiatric Genetics, 153(8), 1417–1424. 
66 
 
Brown, A. B., Biederman, J., Valera, E. M., Doyle, A. E., Bush, G., Spencer, T., … 
Makris, N. (2010). Effect of dopamine transporter gene (SLC6A3) variation on 
dorsal anterior cingulate function in attention‐deficit/hyperactivity disorder. 
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 
153(2), 365–375. 
Brown, R. T., & La Rosa, A. (2002). Recent developments in the pharmacotherapy of 
attention-deficit/hyperactivity disorder (ADHD). Professional Psychology: 
Research and Practice, 33(6), 591. 
Brown, T. (1992). The Brown Attention-Activation Disorder Scale (BAADS). 
Brown, T. E. (2002). DSM–IV: ADHD and executive function impairments. Advanced 
Studies in Medicine, 2(25), 910–914. 
Bush, G., Frazier, J. A., Rauch, S. L., Seidman, L. J., Whalen, P. J., Jenike, M. A., … 
Biederman, J. (1999). Anterior cingulate cortex dysfunction in attention-
deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. 
Biological Psychiatry, 45(12), 1542–1552. 
Calderon, O., & Ruben, L. (2008). A contextual, multidimensional, interdisciplinary 
approach to assessment of ADHD: A best practice clinical model. Best Practices 
in Mental Health: An International Journal, 4(2), 59–79. 
Canu, W. H., & Wymbs, B. T. (2015). Novel approaches to cognitive-behavioral therapy 
for adult ADHD. Cognitive and Behavioral Practice, 22(2), 111–115. 
https://doi.org/10.1016/j.cbpra.2015.01.002 
67 
 
Carmona, S., Vilarroya, O., Bielsa, A., Tremols, V., Soliva, J., Rovira, M., … Batlle, S. 
(2005). Global and regional gray matter reductions in ADHD: a voxel-based 
morphometric study. Neuroscience Letters, 389(2), 88–93. 
Castellanos, F. X., Giedd, J. N., Eckburg, P., Marsh, W. L., Vaituzis, A. C., Kaysen, D., 
… Rapoport, J. L. (1994). Quantitative morphology of the caudate nucleus in 
attention deficit hyperactivity disorder. American Journal of Psychiatry, 151(12), 
1791–1796. 
Castellanos, F. X., Margulies, D. S., Kelly, C., Uddin, L. Q., Ghaffari, M., Kirsch, A., … 
Biswal, B. (2008). Cingulate-precuneus interactions: a new locus of dysfunction 
in adult attention-deficit/hyperactivity disorder. Biological Psychiatry, 63(3), 
332–337. 
Chae, P. K., Kim, J.-H., & Noh, K.-S. (2003). Diagnosis of ADHD among gifted children 
in relation to KEDI-WISC and TOVA performance. Gifted Child Quarterly, 
47(3), 192–201. 
Choi, J. W., Han, D. H., Kang, K. D., Jung, H. Y., & Renshaw, P. F. (2015). Aerobic 
exercise and attention deficit hyperactivity disorder: brain research. Med Sci 
Sports Exerc, 47(1), 33–39. 
Christner, R. W., Stewart, J. L., & Freeman, A. (2007). Handbook of cognitive-behavior 
group therapy with children and adolescents: Specific settings and presenting 
problems. Cambridge Univ Press. 
Clark, L., Blackwell, A. D., Aron, A. R., Turner, D. C., Dowson, J., Robbins, T. W., & 
Sahakian, B. J. (2007). Association between response inhibition and working 
68 
 
memory in adult ADHD: a link to right frontal cortex pathology? Biological 
Psychiatry, 61(12), 1395–1401. 
Combs, M. A., Canu, W. H., Broman-Fulks, J. J., Rocheleau, C. A., & Nieman, D. C. 
(2015). Perceived stress and ADHD symptoms in adults. Journal of Attention 
Disorders, 19(5), 425–434. https://doi.org/10.1177/1087054712459558 
Conners, C. K., Erhardt, D., & Sparrow, E. (2002). Conners’ Adult ADHD Rating 
Scales–Self-Report: Long Version (CAARS–S: L). Retrieved from 
http://www.psychassessments.com.au/products/31/prod31_report3.pdf 
Conners, C. K., Erhardt, D., & Sparrow, E. P. (1999). Conners’ adult ADHD rating scales 
(CAARS): technical manual. MHS North Tonawanda. 
Conners, C. K., & Staff, M. (2000). Conners’ Continuous Performance Test II (CPT II V. 
5). Multi-Health Systems Inc, North Tonawanda, NY. 
Cortese, S., Kelly, C., Chabernaud, C., Proal, E., Di Martino, A., Milham, M. P., & 
Castellanos, F. X. (2012). Toward systems neuroscience of ADHD: a meta-
analysis of 55 fMRI studies. American Journal of Psychiatry. 
Cortese, S., Konofal, E., & Lecendreux, M. (2008). Alertness and feeding behaviors in 
ADHD: does the hypocretin/orexin system play a role? Medical Hypotheses, 
71(5), 770–775. 
Cronbach, L. J., & Meehl, P. E. (1955). Construct validity in psychological tests. 
Psychological Bulletin, 52(4), 281. 
Daley, D. (2006). Attention deficit hyperactivity disorder: a review of the essential facts. 
Child: Care, Health & Development, 32(2), 193–204. 
69 
 
Dan, O., & Raz, S. (2012). The relationships among ADHD, self-esteem, and test anxiety 
in young adults. Journal of Attention Disorders, 1087054712454571. 
Davies, W., Humby, T., Trent, S., Eddy, J. B., Ojarikre, O. A., & Wilkinson, L. S. 
(2014). Genetic and pharmacological modulation of the steroid sulfatase axis 
improves response control; comparison with drugs used in ADHD. 
Neuropsychopharmacology, 39(11), 2622–2632. 
Dodson, W. W. (2005). Pharmacotherapy of adult ADHD. Journal of Clinical 
Psychology, 61(5), 589–606. 
Dovis, S., Van der Oord, S., Huizenga, H. M., Wiers, R. W., & Prins, P. J. M. (2015). 
Prevalence and diagnostic validity of motivational impairments and deficits in 
visuospatial short-term memory and working memory in ADHD subtypes. 
European Child & Adolescent Psychiatry, 24(5), 575–590. 
https://doi.org/10.1007/s00787-014-0612-1 
DSM–5 American Psychiatric Association. (2013). Diagnostic and statistical manual of 
mental disorders. Arlington: American Psychiatric Publishing. 
DSM–IV 1994 American Psychiatric Association. (1994). Diagnostic and statistical 
manual of mental disorders: DSM–IV. 
Edebol, H., Helldin, L., & Norlander, T. (2013). Measuring adult attention deficit 
hyperactivity disorder using the quantified behavior test plus. PsyCh Journal, 
2(1), 48–62. 
Ehlis, A.-C., Bähne, C. G., Jacob, C. P., Herrmann, M. J., & Fallgatter, A. J. (2008). 
Reduced lateral prefrontal activation in adult patients with attention-
deficit/hyperactivity disorder (ADHD) during a working memory task: a 
70 
 
functional near-infrared spectroscopy (fNIRS) study. Journal of Psychiatric 
Research, 42(13), 1060–1067. 
Emond, V., Joyal, C., & Poissant, H. (2009). [Structural and functional neuroanatomy of 
attention-deficit hyperactivity disorder (ADHD)]. L’encéphale, 35(2), 107–114. 
Epstein, J. N., Erkanli, A., Conners, C. K., Klaric, J., Costello, J. E., & Angold, A. 
(2003). Relations between continuous performance test performance measures 
and ADHD behaviors. Journal of Abnormal Child Psychology, 31(5), 543–554. 
Epstein, J. N., Goldberg, N. A., Conners, C. K., & March, J. S. (1997). The effects of 
anxiety on continuous performance test functioning in an ADHD clinic sample. 
Journal of Attention Disorders, 2(1), 45–52. 
Erhardt, D., Epstein, J., Conners, C., Parker, J., & Sitarenios, G. (1999). Self-ratings of 
ADHD symptoms in adults, 2: reliability, validity, and diagnostic sensitivity. J 
Atten Disord, 3(3), 153–158. 
Fallgatter, A. J., Ehlis, A.-C., Seifert, J., Strik, W. K., Scheuerpflug, P., Zillessen, K. E., 
… Warnke, A. (2004). Altered response control and anterior cingulate function in 
attention-deficit/hyperactivity disorder boys. Clinical Neurophysiology, 115(4), 
973–981. 
Faraone, S. V., Biederman, J., & Mick, E. (2006). The age-dependent decline of attention 
deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological 
Medicine, 36(02), 159–165. 
Faraone, S. V., Bonvicini, C., & Scassellati, C. (2014). Biomarkers in the diagnosis of 
ADHD–promising directions. Current Psychiatry Reports, 16(11), 1–20. 
71 
 
Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009). Statistical power analyses 
using G* Power 3.1: Tests for correlation and regression analyses. Behavior 
Research Methods, 41(4), 1149–1160. 
Field, A. (2009). Discovering statistics using SPSS. Sage publications. 
Fischer, M., Barkley, R. A., Smallish, L., & Fletcher, K. (2005). Executive functioning in 
hyperactive children as young adults: attention, inhibition, response perseveration, 
and the impact of comorbidity. Developmental Neuropsychology, 27(1), 107–133. 
Flavell, J. H., Miller, P. H., & Miller, S. A. (1985). Cognitive development. Prentice-Hall 
Englewood Cliffs, NJ. 
Franke, B. (2015). ADHD across the lifespan—impact on genetics of adult ADHD. 
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 
168(6), 403–405. https://doi.org/10.1002/ajmg.b.32342 
Frodl, T., & Skokauskas, N. (2012). Meta‐analysis of structural MRI studies in children 
and adults with attention deficit hyperactivity disorder indicates treatment effects. 
Acta Psychiatrica Scandinavica, 125(2), 114–126. 
Goldman-Rakic, P. S. (1995). Anatomical and functional circuits in prefrontal cortex of 
nonhuman primates: Relevance to epilepsy. Raven Press. 
Goldstein, S., & Ellison, A. T. (2002). Clinicians’ guide to adult ADHD: Assessment and 
intervention. (S. Goldstein & A. T. Ellison, Eds.). San Diego, CA, US: Academic 
Press. Retrieved from 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=psyh&AN=2002-06375-000&site=eds-live&scope=site 
72 
 
Gordon, M., McClure, F. D., & Aylward, G. P. (1996). Gordon Diagnostic System 
Interpretive Guide. 
Goto, Y., & Grace, A. A. (2005). Dopaminergic modulation of limbic and cortical drive 
of nucleus accumbens in goal-directed behavior. Nature Neuroscience, 8(6), 805–
812. 
Hale, T. S., Bookheimer, S., McGough, J. J., Phillips, J. M., & McCracken, J. T. (2007). 
Atypical brain activation during simple & complex levels of processing in adult 
ADHD: an fMRI study. Journal of Attention Disorders. 
Hall, C. L. ( 1 ), Valentine, A. Z. ( 1 ), Walker, G. M. ( 1 ), Hollis, C. ( 1, 6,7 ), Groom, 
M. J. ( 2 ), Sayal, K. ( 3, 4 ), & Daley, D. ( 4, 5 ). (2015). The clinical utility of the 
continuous performance test and objective measures of activity for diagnosing and 
monitoring ADHD in children: a systematic review. European Child and 
Adolescent Psychiatry, 1–23. https://doi.org/10.1007/s00787-015-0798-x 
Hall, S., Halperin, J., Schwartz, S., & Newcorn, J. (1997). Behavioral and executive 
functions in children with attention-deficit hyperactivity disorder and reading 
disability. Journal of Attention Disorders, 1(4), 235–243. 
Heiser, P., Frey, J., Smidt, J., Sommerlad, C., Wehmeier, P., Hebebrand, J., & 
Remschmidt, H. (2004). Objective measurement of hyperactivity, impulsivity, 
and inattention in children with hyperkinetic disorders before and after treatment 
with methylphenidate. European Child & Adolescent Psychiatry, 13(2), 100–104. 
Hill, J. C., & Schoener, E. P. (1996). Age-dependent decline of attention deficit 
hyperactivity disorder. The American Journal of Psychiatry, 153(9), 1143. 
73 
 
Hines, J. L., King, T. S., & Curry, W. J. (2012). The adult ADHD self-report scale for 
screening for adult attention deficit–hyperactivity disorder (ADHD). The Journal 
of the American Board of Family Medicine, 25(6), 847–853. 
Hynd, G. W., Hern, K. L., Novey, E. S., Eliopulos, D., Marshall, R., Gonzalez, J. J., & 
Voeller, K. K. (1993). Attention deficit-hyperactivity disorder and asymmetry of 
the caudate nucleus. Journal of Child Neurology, 8(4), 339–347. 
Ikemoto, S., & Panksepp, J. (1999). The role of nucleus accumbens dopamine in 
motivated behavior: a unifying interpretation with special reference to reward-
seeking. Brain Research Reviews, 31(1), 6–41. 
Jadidian, A., Hurley, R. A., & Taber, K. H. (2015). Neurobiology of adult ADHD: 
Emerging evidence for network dysfunctions. The Journal of Neuropsychiatry 
and Clinical Neurosciences, 27(3), 172–178. 
https://doi.org/10.1176/appi.neuropsych.15060142 
Jensen, P. S. (2001). —Introduction—: ADHD Comorbidity and Treatment Outcomes in 
the MTA. Journal of the American Academy of Child & Adolescent Psychiatry, 
40(2), 134–136. 
Jensen, P. S., Kettle, L., Roper, M. T., Sloan, M. T., Dulcan, M. K., Hoven, C., … Payne, 
J. D. (1999). Are stimulants overprescribed? Treatment of ADHD in four US 
communities. Journal of the American Academy of Child & Adolescent 
Psychiatry, 38(7), 797–804. 
Jiang, Y., & Johnston, C. (2011). The relationship between ADHD symptoms and 
competence as reported by both self and others. Journal of Attention Disorders, 
1087054710392541. 
74 
 
Kanfer, F. H., & Karoly, P. (1972). Self-control: A behavioristic excursion into the lion’s 
den. Behavior Therapy, 3(3), 398–416. 
Kennedy, C. H. (2007). Components of Adult ADHD Assessment and Treatment. 
PsycCRITIQUES, 52(21). https://doi.org/10.1037/a0006946 
Kern, J. K., Geier, D. A., Sykes, L. K., Geier, M. R., & Deth, R. C. (2015). Are ASD and 
ADHD a continuum? A comparison of pathophysiological similarities between 
the disorders. Journal of Attention Disorders, 19(9), 805–827. 
Kessel, J. B., & Zimmerman, M. (1993). Reporting errors in studies of the diagnostic 
performance of self-administered questionnaires: extent of the problem, 
recommendations for standardized presentation of results, and implications for the 
peer review process. Psychological Assessment, 5(4), 395. 
Kessler, R. C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., … Spencer, T. 
(2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS): 
a short screening scale for use in the general population. Psychological Medicine, 
35(02), 245–256. 
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., … 
Secnik, K. (2006). The prevalence and correlates of adult ADHD in the United 
States: results from the National Comorbidity Survey Replication. American 
Journal of Psychiatry. 
Keune, P. M., Wiedemann, E., Schneidt, A., & Schönenberg, M. (2015). Frontal brain 
asymmetry in adult attention-deficit/hyperactivity disorder (ADHD): Extending 
the motivational dysfunction hypothesis. Clinical Neurophysiology, 126(4), 711–
720. https://doi.org/10.1016/j.clinph.2014.07.008 
75 
 
Kim, C.-H., Hahn, M. K., Joung, Y., Anderson, S. L., Steele, A. H., Mazei-Robinson, M. 
S., … Robertson, D. (2006). A polymorphism in the norepinephrine transporter 
gene alters promoter activity and is associated with attention-deficit hyperactivity 
disorder. Proceedings of the National Academy of Sciences, 103(50), 19164–
19169. 
Kim, J., Lee, Y., Han, D., Min, K., Kim, D., & Lee, C. (2015). The utility of quantitative 
electroencephalography and Integrated Visual and Auditory Continuous 
Performance Test as auxiliary tools for the Attention Deficit Hyperactivity 
Disorder diagnosis. Clinical Neurophysiology, 126(3), 532–540. 
King, J. A., Colla, M., Brass, M., Heuser, I., & von Cramon, D. Y. (2007). Inefficient 
cognitive control in adult ADHD: evidence from trial-by-trial Stroop test and 
cued task switching performance. Behavioral and Brain Functions, 3(1), 1. 
Klassen, L. J., Katzman, M. A., & Chokka, P. (2010). Adult ADHD and its 
comorbidities, with a focus on bipolar disorder. Journal of Affective Disorders, 
124(1), 1–8. 
Knobel, M., Wolman, M. B., & Mason, E. (1959). Hyperkinesis and organicity in 
children. A.M.A. Archives of General Psychiatry, 1(3), 310–321. 
https://doi.org/10.1001/archpsyc.1959.03590030094011 
Knouse, L. E. (2015). Cognitive-behavioral therapies for ADHD. In R. A. Barkley & R. 
A. (Ed) Barkley (Eds.), Attention-deficit hyperactivity disorder: A handbook for 
diagnosis and treatment (4th ed.). (pp. 757–773). New York, NY, US: Guilford 
Press. Retrieved from 
76 
 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=psyh&AN=2014-57877-032&site=eds-live&scope=site 
Knouse, L. E., Bagwell, C. L., Barkley, R. A., & Murphy, K. R. (2005). Accuracy of self-
evaluation in adults with ADHD evidence from a driving study. Journal of 
Attention Disorders, 8(4), 221–234. 
Kofler, M. J., Alderson, R. M., Raiker, J. S., Bolden, J., Sarver, D. E., & Rapport, M. D. 
(2014). Working memory and intraindividual variability as neurocognitive 
indicators in ADHD: Examining competing model predictions. Neuropsychology, 
28(3), 459–471. https://doi.org/10.1037/neu0000050 
Kollins, S., Anastopoulos, A. D., Lachiewicz, A., FitzGerald, D., Morrissey‐Kane, E., 
Garrett, M., … Ashley‐Koch, A. (2008). SNPs in dopamine D2 receptor gene 
(DRD2) and norepinephrine transporter gene (NET) are associated with 
continuous performance task (CPT) phenotypes in ADHD children and their 
families. American Journal of Medical Genetics Part B: Neuropsychiatric 
Genetics, 147(8), 1580–1588. 
Konishi, S., Nakajima, K., Uchida, I., Kikyo, H., Kameyama, M., & Miyashita, Y. 
(1999). Common inhibitory mechanism in human inferior prefrontal cortex 
revealed by event-related functional MRI. Brain, 122(5), 981–991. 
Konrad, K., & Eickhoff, S. B. (2010). Is the ADHD brain wired differently? A review on 
structural and functional connectivity in attention deficit hyperactivity disorder. 
Human Brain Mapping, 31(6), 904–916. 
Kooij, J. S., Boonstra, A. M., Swinkels, S., Bekker, E. M., de Noord, I., & Buitelaar, J. K. 
(2008). Reliability, validity, and utility of instruments for self-report and 
77 
 
informant report concerning symptoms of ADHD in adult patients. Journal of 
Attention Disorders, 11(4), 445–458. 
Koziol, L. F., & Stout, C. E. (1992). Use of a verbal fluency measure in understanding 
and evaluating ADHD as an executive function disorder. Perceptual and Motor 
Skills, 75(3f), 1187–1192. 
Krain, A. L., & Castellanos, F. X. (2006). Brain development and ADHD. Clinical 
Psychology Review, 26(4), 433–444. 
Krause, J., la Fougere, C., Krause, K.-H., Ackenheil, M., & St H, D. (2005). Influence of 
striatal dopamine transporter availability on the response to methylphenidate in 
adult patients with ADHD. European Archives of Psychiatry and Clinical 
Neuroscience, 255(6), 428–431. 
Laufer, M. W., Denhoff, E., & Solomons, G. (1957). Hyperkinetic impulse disorder in 
children’s behavior problems. Psychosomatic Medicine, 19(1), 38–49. 
Lee, J. S., Kim, B. N., Kang, E., Lee, D. S., Kim, Y. K., Chung, J., … Cho, S. C. (2005). 
Regional cerebral blood flow in children with attention deficit hyperactivity 
disorder: comparison before and after methylphenidate treatment. Human Brain 
Mapping, 24(3), 157–164. 
Lenartowicz, A., & Loo, S. K. (2014). Use of EEG to Diagnose ADHD. Current 
Psychiatry Reports, 16(11), 1–11. 
Lijffijt, M., Kenemans, J. L., Verbaten, M. N., & van Engeland, H. (2005). A meta-
analytic review of stopping performance in attention-deficit/hyperactivity 
disorder: deficient inhibitory motor control? Journal of Abnormal Psychology, 
114(2), 216. 
78 
 
Linnenbrink, E. A., & Pintrich, P. R. (2002). Motivation as an enabler for academic 
success. School Psychology Review, 31(3), 313. 
Lis, S., Baer, N., Stein‐en‐Nosse, C., Gallhofer, B., Sammer, G., & Kirsch, P. (2010). 
Objective measurement of motor activity during cognitive performance in adults 
with attention‐deficit/hyperactivity disorder. Acta Psychiatrica Scandinavica, 
122(4), 285–294. 
Ljusberg, A.-L., & Brodin, J. (2007). Self-concept in children with attention deficits. 
International Journal of Rehabilitation Research, 30(3), 195–201. 
Loo, S. K., & Arns, M. (2015). Should the EEG–Based Theta to Beta Ratio Be Used to 
Diagnose ADHD? The ADHD Report, 23(8), 8–13. 
Losier, B. J., McGrath, P. J., & Klein, R. M. (1996). Error Patterns on the Continuous 
Performance Test in Non‐Medicated and Medicated Samples of Children With 
and Without ADHD: A Meta‐Analytic Review. Journal of Child Psychology and 
Psychiatry, 37(8), 971–987. 
Matier, K., Halperin, J. M., Sharma, V., Newcorn, J. H., & Sathaye, N. (1992). 
Methylphenidate response in aggressive and nonaggressive ADHD children: 
Distinctions on laboratory measures of symptoms. Journal of the American 
Academy of Child & Adolescent Psychiatry, 31(2), 219–225. 
Mayes, S. D., Calhoun, S. L., Bixler, E. O., Vgontzas, A. N., Mahr, F., Hillwig-Garcia, J., 
… Parvin, M. (2009). ADHD subtypes and comorbid anxiety, depression, and 
oppositional-defiant disorder: differences in sleep problems. Journal of Pediatric 
Psychology, 34(3), 328–337. 
79 
 
McLoughlin, G., Albrecht, B., Banaschewski, T., Rothenberger, A., Brandeis, D., 
Asherson, P., & Kuntsi, J. (2009). Performance monitoring is altered in adult 
ADHD: a familial event-related potential investigation. Neuropsychologia, 
47(14), 3134–3142. 
Messick, S. (1995). Validity of psychological assessment: validation of inferences from 
persons’ responses and performances as scientific inquiry into score meaning. 
American Psychologist, 50(9), 741. 
Mészáros, Á., Czobor, P., Bálint, S., Komlósi, S., Simon, V., & Bitter, I. (2009). 
Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a 
meta-analysis. International Journal of Neuropsychopharmacology, 12(8), 1137–
1147. 
Milner, B. (1995). Aspects of human frontal lobe function. 
Mitchell, J., Benson, J., Knouse, L., Kimbrel, N., & Anastopoulos, A. (2013). Are 
Negative Automatic Thoughts Associated with ADHD in Adulthood? Cognitive 
Therapy & Research, 37(4), 851–859. 
Mohamed, S. M. H., Börger, N. A., Geuze, R. H., & van der Meere, J. J. (2015). Self-
reported ADHD symptoms and interhemispheric interaction in adults: A 
dimensional approach. Behavioural Neurology, 2015. Retrieved from 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=psyh&AN=2015-25328-001&site=eds-live&scope=site 
Montano, C. B., & Weisler, R. (2011). Distinguishing symptoms of ADHD from other 
psychiatric disorders in the adult primary care setting. Postgraduate Medicine, 
123(3), 88–98. 
80 
 
Mörstedt, B., Corbisiero, S., Bitto, H., & Stieglitz, R.-D. (2015). Attention-
Deficit/Hyperactivity Disorder (ADHD) in Adulthood: Concordance and 
Differences between Self- and Informant Perspectives on Symptoms and 
Functional Impairment. PLoS ONE, 10(10), 1–15. 
Murillo, L. G., Cortese, S., Anderson, D., Di Martino, A., & Castellanos, F. X. (2015). 
Locomotor activity measures in the diagnosis of attention deficit hyperactivity 
disorder: Meta-analyses and new findings. Journal of Neuroscience Methods, 252, 
14–26. 
Murphy, K., & Barkley, R. A. (1996). Attention deficit hyperactivity disorder adults: 
comorbidities and adaptive impairments. Comprehensive Psychiatry, 37(6), 393–
401. 
Murray, K. T., & Kochanska, G. (2002). Effortful control: Factor structure and relation to 
externalizing and internalizing behaviors. Journal of Abnormal Child Psychology, 
30(5), 503–514. 
Nelson, J. M. (2011). Self-concept of college students with ADHD: Discordance between 
self-and parent-reports. Journal of Attention Disorders, 1087054711430331. 
Nigg, J. (2015). ADHD: New Approaches to Subtyping and Nosology. The ADHD 
Report, 23(2), 6–9. 
Nigg, J. T., Blaskey, L. G., Huang-Pollock, C. L., & Rappley, M. D. (2002). 
Neuropsychological executive functions and DSM–IV ADHD subtypes. Journal 
of the American Academy of Child & Adolescent Psychiatry, 41(1), 59–66. 
Nigg, J. T., Willcutt, E. G., Doyle, A. E., & Sonuga-Barke, E. J. (2005). Causal 
heterogeneity in attention-deficit/hyperactivity disorder: do we need 
81 
 
neuropsychologically impaired subtypes? Biological Psychiatry, 57(11), 1224–
1230. 
O’Brien, D. R. (2016). The Association of Cognitive Distortions, Problems with Self-
Concept, Gender, and Age in Adults Diagnosed with Attention-
Deficit/Hyperactivity Disorder (ADHD). 
Øgrim, G. (2014). Electrophysiology in ADHD Diagnosis, predictions, and treatment. 
O’Hara, B., Smith, S., Bird, G., Persico, A., Suarez, B., Cutting, G., & Uhl, G. (1993). 
Dopamine D2 receptor RFLPs, haplotypes and their association with substance 
use in black and Caucasian research volunteers. Human Heredity, 43(4), 209–218. 
Ossmann, J. M., & Mulligan, N. W. (2003). Inhibition and attention deficit hyperactivity 
disorder in adults. The American Journal of Psychology. 
Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014). 
ADHD prevalence estimates across three decades: an updated systematic review 
and meta-regression analysis. International Journal of Epidemiology, 43(2), 434–
442. 
Polier, G., Vloet, T., & Herpertz‐Dahlmann, B. (2012). ADHD and delinquency–a 
developmental perspective. Behavioral Sciences & the Law, 30(2), 121–139. 
Prevatt, F., Proctor, B., Best, L., Baker, L., Van Walker, J., & Taylor, N. W. (2011). The 
positive illusory bias: Does it explain self-evaluations in college students with 
ADHD? Journal of Attention Disorders, 1087054710392538. 
Prince, J. B., Wilens, T. E., Spencer, T. J., & Biederman, J. (2015). Pharmacotherapy of 
ADHD in adults. In R. A. Barkley & R. A. Barkley (Eds.), Attention-deficit 
hyperactivity disorder: A handbook for diagnosis and treatment (4th ed., pp. 826–
82 
 
860). New York, NY: Guilford Press. Retrieved from 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=psyh&AN=2014-57877-035&site=eds-live&scope=site 
Quay, H. C. (1997). Inhibition and attention deficit hyperactivity disorder. Journal of 
Abnormal Child Psychology, 25(1), 7–13. 
Ramsay, J. R. (2007). Current status of cognitive-behavioral therapy as a psychosocial 
treatment for adult attention-deficit/hyperactivity disorder. Current Psychiatry 
Reports, 9(5), 427–433. 
Ramsay, J. R. (2010a). ADHD in adulthood. In Nonmedication treatments for adult 
ADHD: Evaluating impact on daily functioning and well-being. (pp. 9–35). 
Washington, DC, US: American Psychological Association. Retrieved from 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=psyh&AN=2009-08919-001&site=eds-live&scope=site 
Ramsay, J. R. (2010b). ADHD in adulthood. In Nonmedication treatments for adult 
ADHD: Evaluating impact on daily functioning and well-being. (pp. 9–35). 
Washington, DC, US: American Psychological Association. Retrieved from 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=psyh&AN=2009-08919-001&site=eds-live&scope=site 
Ramsay, J. R. (2010c). CBT for Adult ADHD: Adaptations and Hypothesized 
Mechanisms of Change. Journal of Cognitive Psychotherapy, 24(1), 37–45. 
Ramsay, J. R. (2012). “Without a net”: CBT without medications for an adult with 
ADHD. Clinical Case Studies, 11(1), 48–65. 
https://doi.org/10.1177/1534650112440741 
83 
 
Ramsay, J. R., & Rostain, A. L. (2011). CBT Without Medications for Adult ADHD: An 
Open Pilot Study of Five Patients. Journal of Cognitive Psychotherapy, 25(4), 
277–286. 
Ramsey, J. R., & Rostain, A. L. (2005). Attention-Deficit/Hyperactivity Disorder 
(ADHD)-Adult. In Encyclopedia of Cognitive Behavior Therapy (pp. 52–54). 
Springer. 
Rasmussen, K., & Levander, S. (2009). Untreated ADHD in Adults Are There Sex 
Differences in Symptoms, Comorbidity, and Impairment? Journal of Attention 
Disorders, 12(4), 353–360. 
Ray, L. A., Miranda Jr, R., Tidey, J. W., McGeary, J. E., MacKillop, J., Gwaltney, C. J., 
… Monti, P. M. (2010). Polymorphisms of the μ-opioid receptor and dopamine 
D₄ receptor genes and subjective responses to alcohol in the natural environment. 
Journal of Abnormal Psychology, 119(1), 115. 
Rhodes, S. M., Coghill, D. R., & Matthews, K. (2004). Methylphenidate restores visual 
memory, but not working memory function in attention deficit-hyperkinetic 
disorder. Psychopharmacology, 175(3), 319–330. 
Riccio, C. A., & Reynolds, C. R. (2001). Continuous performance tests are sensitive to 
ADHD in adults but lack specificity. Annals of the New York Academy of 
Sciences, 931(1), 113–139. 
Ridderinkhof, K. R., Van Den Wildenberg, W. P., Segalowitz, S. J., & Carter, C. S. 
(2004). Neurocognitive mechanisms of cognitive control: the role of prefrontal 
cortex in action selection, response inhibition, performance monitoring, and 
reward-based learning. Brain and Cognition, 56(2), 129–140. 
84 
 
Robb, J. A., Sibley, M. H., Pelham Jr, W. E., Foster, E. M., Molina, B. S., Gnagy, E. M., 
& Kuriyan, A. B. (2011). The estimated annual cost of ADHD to the US 
education system. School Mental Health, 3(3), 169–177. 
Rosenfield, Bradley M, Ramsay, J. R., & Rostain, A. L. (2008). Extreme makeover: The 
case of a young adult man with severe ADHD. Clinical Case Studies. 
Rosenfield, Bradley Michael. (2004). Relationship between cognitive distortions and 
psychological disorders across diagnostic axes. 
Rostain, A., Jensen, P. S., Connor, D. F., Miesle, L. M., & Faraone, S. V. (2015). Toward 
quality care in ADHD: Defining the goals of treatment. Journal of Attention 
Disorders, 19(2), 99–117. https://doi.org/10.1177/1087054712473835 
Rubia, K., Smith, A. B., Brammer, M. J., & Taylor, E. (2003). Right inferior prefrontal 
cortex mediates response inhibition while mesial prefrontal cortex is responsible 
for error detection. Neuroimage, 20(1), 351–358. 
Rucklidge, J. J., & Tannock, R. (2001). Psychiatric, psychosocial, and cognitive 
functioning of female adolescents with ADHD. Journal of the American Academy 
of Child & Adolescent Psychiatry, 40(5), 530–540. 
Saad, J. F., Kohn, M. R., Clarke, S., Lagopoulos, J., & Hermens, D. F. (2015). Is the 
Theta/Beta EEG Marker for ADHD Inherently Flawed? Journal of Attention 
Disorders, 1087054715578270. 
Schachar, R., Mota, V. L., Logan, G. D., Tannock, R., & Klim, P. (2000). Confirmation 
of an inhibitory control deficit in attention-deficit/hyperactivity disorder. Journal 
of Abnormal Child Psychology, 28(3), 227–235. 
85 
 
Schecklmann, M., Romanos, M., Bretscher, F., Plichta, M. M., Warnke, A., & Fallgatter, 
A. J. (2010). Prefrontal oxygenation during working memory in ADHD. Journal 
of Psychiatric Research, 44(10), 621–628. 
Schneider, M. F., Krick, C. M., Retz, W., Hengesch, G., Retz-Junginger, P., Reith, W., & 
Rösler, M. (2010). Impairment of fronto-striatal and parietal cerebral networks 
correlates with attention deficit hyperactivity disorder (ADHD) psychopathology 
in adults—a functional magnetic resonance imaging (fMRI) study. Psychiatry 
Research: Neuroimaging, 183(1), 75–84. 
Seidman, L. J., Biederman, J., Weber, W., Hatch, M., & Faraone, S. V. (1998). 
Neuropsychological function in adults with attention-deficit hyperactivity 
disorder. Biological Psychiatry, 44(4), 260–268. 
Seidman, L. J., Valera, E. M., Makris, N., Monuteaux, M. C., Boriel, D. L., Kelkar, K., 
… Aleardi, M. (2006). Dorsolateral prefrontal and anterior cingulate cortex 
volumetric abnormalities in adults with attention-deficit/hyperactivity disorder 
identified by magnetic resonance imaging. Biological Psychiatry, 60(10), 1071–
1080. 
Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2014). Emotion dysregulation in 
attention deficit hyperactivity disorder. American Journal of Psychiatry. 
Shemmassian, S. K. (2015). Optimizing assessment procedures for attention-
deficit/hyperactivity disorder (adhd). ProQuest Information & Learning, US. 
Retrieved from 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=psyh&AN=2015-99060-268&site=eds-live&scope=site 
86 
 
Smith, A., Taylor, E., Warner Rogers, J., Newman, S., & Rubia, K. (2002). Evidence for 
a pure time perception deficit in children with ADHD. Journal of Child 
Psychology and Psychiatry, 43(4), 529–542. 
Snyder, S. M., Rugino, T. A., Hornig, M., & Stein, M. A. (2015). Integration of an EEG 
biomarker with a clinician’s ADHD evaluation. Brain and Behavior, 5(4). 
Solanto, M. V. (2015). Executive function deficits in adults with ADHD. In R. A. 
Barkley & R. A. (Ed) Barkley (Eds.), Attention-deficit hyperactivity disorder: A 
handbook for diagnosis and treatment (4th ed.). (pp. 256–266). New York, NY, 
US: Guilford Press. Retrieved from 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=psyh&AN=2014-57877-010&site=eds-live&scope=site 
Sonuga-Barke, E. J. (2002). Psychological heterogeneity in AD/HD—a dual pathway 
model of behaviour and cognition. Behavioural Brain Research, 130(1), 29–36. 
Spalletta, G., Pasini, A., Pau, F., Guido, G., Menghini, L., & Caltagirone, C. (2001). 
Prefrontal blood flow dysregulation in drug naive ADHD children without 
structural abnormalities. Journal of Neural Transmission, 108(10), 1203–1216. 
Stein, M. A., Snyder, S. M., Rugino, T. A., & Hornig, M. (2016). Commentary: 
Objective aids for the assessment of ADHD: Further clarification of what FDA 
approval for marketing means and why NEBA might help clinicians. A response 
to Arns et al.(2016). Journal of Child Psychology and Psychiatry, 57(6), 770–771. 
Stevenson, J., Asherson, P., Hay, D., Levy, F., Swanson, J., Thapar, A., & Willcutt, E. 
(2005). Characterizing the ADHD phenotype for genetic studies. Developmental 
Science, 8(2), 115–121. https://doi.org/10.1111/j.1467-7687.2005.00398.x 
87 
 
Still, G. F., & Cantab, L. (1902). The Goulstonian Lectures ON SOME ABNORMAL 
PSYCHICAL CONDITIONS IN CHILDREN. Originally Published as Volume 1, 
Issue 4102, 159(4102), 1008–1013. https://doi.org/10.1016/S0140-
6736(01)74984-7 
Strohl, M. P. (2011). Bradley’s Benzedrine studies on children with behavioral disorders. 
The Yale Journal of Biology and Medicine, 84(1), 27. 
Strohmeier, C. (2013). Adult ADHD and the relationship between self-reported frequency 
of cognitive distortions, anxiety, and depression. 2013. Retrieved from 
http://ezproxy.pcom.edu:2048/login?url=http://search.ebscohost.com/login.aspx?d
irect=true&db=cat00201a&AN=pcom.40687&site=eds-live&scope=site 
Strohmeier, C. W., Rosenfield, B., DiTomasso, R. A., & Ramsay, J. R. (n.d.). Assessment 
of the relationship between self-reported cognitive distortions and adult ADHD, 
anxiety, depression, and hopelessness. Psychiatry Research, 238, 153–158. 
https://doi.org/10.1016/j.psychres.2016.02.034 
Sumner, C. R. (2010). New tool for objective assessments of ADHD: The QuotientTM 
ADHD System. ADHD Report,18(5), 6–9. 
Swanson, J., Flodman, P., Kennedy, J., Spence, M. A., Moyzis, R., Schuck, S., … Smith, 
M. (2000). Dopamine genes and ADHD. Neuroscience & Biobehavioral Reviews, 
24(1), 21–25. 
Tabassam, W., & Grainger, J. (2002). Self-concept, attributional style and self-efficacy 
beliefs of students with learning disabilities with and without attention deficit 
hyperactivity disorder. Learning Disability Quarterly, 25(2), 141–151. 
88 
 
Teicher, M. H., Ito, Y., Glod, C. A., & Barber, N. I. (1996). Objective measurement of 
hyperactivity and attentional problems in ADHD. Journal of the American 
Academy of Child and Adolescent Psychiatry, 35(3), 334–342. 
Teicher, M. H., Lowen, S. B., Polcari, A., Foley, M., & McGreenery, C. E. (2004). Novel 
strategy for the analysis of CPT data provides new insight into the effects of 
methylphenidate on attentional states in children with ADHD. Journal of Child 
and Adolescent Psychopharmacology, 14(2), 219–232. 
Teicher, M. H., Polcari, A., Fourligas, N., Vitaliano, G., & Navalta, C. P. (2012). 
Hyperactivity persists in male and female adults with ADHD and remains a 
highly discriminative feature of the disorder: a case-control study. BMC 
Psychiatry, 12(1), 190. 
Teicher, M. H., Polcari, A., & McGreenery, C. E. (2008). Utility of objective measures of 
activity and attention in the assessment of therapeutic response to stimulants in 
children with attention-deficit/hyperactivity disorder. Journal of Child and 
Adolescent Psychopharmacology, 18(3), 265–270. 
Thissen, A. J. A. M., Bralten, J., Rommelse, N. N. J., Arias‐Vasquez, A., Greven, C. U., 
Heslenfeld, D., … Buitelaar, J. K. (2015). The role of age in association analyses 
of ADHD and related neurocognitive functioning: A proof of concept for 
dopaminergic and serotonergic genes. American Journal of Medical Genetics Part 
B: Neuropsychiatric Genetics, 168(6), 471–479. 
https://doi.org/10.1002/ajmg.b.32290 
89 
 
Tian, L., Jiang, T., Liang, M., Zang, Y., He, Y., Sui, M., & Wang, Y. (2008). Enhanced 
resting-state brain activities in ADHD patients: a fMRI study. Brain and 
Development, 30(5), 342–348. 
Tiemeier, H., Lenroot, R. K., Greenstein, D. K., Tran, L., Pierson, R., & Giedd, J. N. 
(2010). Cerebellum development during childhood and adolescence: a 
longitudinal morphometric MRI study. Neuroimage, 49(1), 63–70. 
Tinius, T. P. (2003). The integrated visual and auditory continuous performance test as a 
neuropsychological measure. Archives of Clinical Neuropsychology, 18(5), 439–
454. 
Trifilieff, P., Feng, B., Urizar, E., Winiger, V., Ward, R. D., Taylor, K. M., … Simpson, 
E. H. (2013). Increasing dopamine D2 receptor expression in the adult nucleus 
accumbens enhances motivation. Molecular Psychiatry, 18(9), 1025–1033. 
Turgay, A., Goodman, D. W., Asherson, P., Lasser, R. A., Babcock, T. F., Pucci, M. L., 
& Barkley, R. (2012). Lifespan persistence of ADHD: the life transition model 
and its application. The Journal of Clinical Psychiatry, 73(2), 192–201. 
US Food and Drug Administration. (2013). De novo classification request for 
Neuropsychiatric EEG-Based Assessment Aid for ADHD (NEBA) System. 2013. 
Valera, E. M., Faraone, S. V., Murray, K. E., & Seidman, L. J. (2007). Meta-analysis of 
structural imaging findings in attention-deficit/hyperactivity disorder. Biological 
Psychiatry, 61(12), 1361–1369. 
Verbruggen, F., & Logan, G. D. (2008). Response inhibition in the stop-signal paradigm. 
Trends in Cognitive Sciences, 12(11), 418–424. 
90 
 
Volkow, N. D., Wang, G.-J., Newcorn, J., Telang, F., Solanto, M. V., Fowler, J. S., … 
Pradhan, K. (2007). Depressed dopamine activity in caudate and preliminary 
evidence of limbic involvement in adults with attention-deficit/hyperactivity 
disorder. Archives of General Psychiatry, 64(8), 932–940. 
Wang, L.-J., Huang, Y.-S., Chiang, Y.-L., Hsiao, C.-C., Shang, Z.-Y., & Chen, C.-K. 
(2011). Clinical symptoms and performance on the continuous performance test 
in children with attention deficit hyperactivity disorder between subtypes: a 
natural follow-up study for 6 months. BMC Psychiatry, 11(1), 1. 
Wang, X., Cao, Q., Wang, J., Wu, Z., Wang, P., Sun, L., … Wang, Y. (2016). The effects 
of cognitive-behavioral therapy on intrinsic functional brain networks in adults 
with attention-deficit/hyperactivity disorder. Behaviour Research and Therapy, 
76, 32–39. 
Wilens, T. E., Biederman, J., & Spencer, T. J. (2002). Attention deficit/hyperactivity 
disorder across the lifespan. Annual Review of Medicine, 53(1), 113–131. 
Wilens, T. E., Biederman, J., Spencer, T. J., & Frances, R. J. (1994). Comorbidity of 
attention-deficit hyperactivity and psychoactive substance use disorders. 
Psychiatric Services, 45(5), 421–435. 
Wu, J., Xiao, H., Sun, H., Zou, L., & Zhu, L.-Q. (2012). Role of dopamine receptors in 
ADHD: a systematic meta-analysis. Molecular Neurobiology, 45(3), 605–620. 
Young, S. (2002). A model of psychotherapy for adults with ADHD. Clinician’s Guide to 
Adult ADHD: Assessment and Intervention. San Diego: Academic Press. P, 147–
158. 
91 
 
Young, S. (2005). Coping strategies used by adults with ADHD. Personality and 
Individual Differences, 38(4), 809–816. 
Young, S., Toone, B., & Tyson, C. (2003). Comorbidity and psychosocial profile of 
adults with attention deficit hyperactivity disorder. Personality and Individual 
Differences, 35(4), 743–755. 
Yu-Feng, Z., Yong, H., Chao-Zhe, Z., Qing-Jiu, C., Man-Qiu, S., Meng, L., … Yu-Feng, 
W. (2007). Altered baseline brain activity in children with ADHD revealed by 
resting-state functional MRI. Brain and Development, 29(2), 83–91. 
Zametkin AJ, & Ernst M. (1999). Problems in the management of attention-deficit-
hyperactivity disorder. New England Journal of Medicine, 340(1), 40-46 7p. 
 
 
 
 
 
 
 
